7 days in healthcare (March 16th-22nd, 2026)

 

Summary

The most impactful health news of the week included:

  • Biomedicine: Immune cells with a bait are more effective at hunting cancer cells.
  • Global Health: The US is considering withdrawing HIV aid to Zambia unless it facilitates access to certain minerals.
  • International Health Policy: A judge suspends the Trump Administration’s vaccine recommendations.
  • National Health Policy: The second week of the strike ends with hundreds of thousands of canceled appointments and no progress made between doctors and the Ministry of Health.
  • Business: Privately run hospitals in Madrid achieve better results than publicly managed ones, according to a study.

Biomedicine

  • Immune cells with a bait are more effective at hunting cancer cells. Research has developed stronger, longer-lasting, and more precise T lymphocytes against prostate tumors, paving the way for the development of more potent immunotherapies.
  • Women who experience menopause before age 40 have a higher risk of myocardial infarction. A new study supports this finding.

Global Health

  • The US is considering withdrawing HIV aid to Zambia unless it facilitates access to certain minerals. This is according to a draft memo from the State Department. As with everything, the United States applies the same transactional approach to health aid to developing countries as it does to other activities.
  • Health and war in Sudan. The humanitarian crisis is growing amid international indifference.

International Health Policy

  • A judge suspends the Trump Administration’s vaccine recommendations. A federal judge overturned Robert F. Kennedy, Jr.’s vaccine recommendations, ruling that they were not based on science.
  • The COVID-19 pandemic brought the UK’s healthcare system to the brink of collapse. The service was ill-prepared and forced professionals to put their lives at risk. And what’s worse, both the King’s Fund and the Nuffield Trust, two important British health think tanks, doubt that the NHS would be better prepared if another pandemic were to occur now. An excellent report by Baroness Hallett, far superior to the official report produced in Spain.

National Health Policy (Spain)

  • The second week of the strike ends with hundreds of thousands of canceled appointments and no progress in negotiations between doctors and the Ministry of Health. Various political parties (PP, Vox, ERC, Junts) and autonomous communities (Castilla y León, the Canary Islands, and the Basque Country) are calling for negotiations with the Ministry, which appears to be an obligation of the Administration.
  • 74% of citizens prefer public healthcare for complex cases, compared to 24% who choose private healthcare. The 061 and 112 emergency services are consolidated as the best-rated in the system, according to the 2025 Health Barometer, prepared by the CIS (Spanish Centre for Sociological Research) and the Ministry of Health.
  •  Padilla (Secretary of State for Health) defends the confidentiality of drug prices. The Secretary of State for Health points out that “publishing the net price could create a barrier to access to innovative medicines in Spain.” A responsible position, undoubtedly.

Companies

  • International
    • Ozempic about to become a generic in India, China, and Canada. Novo Nordisk is about to lose patent protection in those countries.
  • National
    • Privately managed hospitals in Madrid achieve better results than publicly managed ones, according to a study. Research published in ‘Healthcare’ compares efficiency and quality of care indicators between privately managed centers and traditional SERMAS hospitals, always based on published official data. The privately managed hospitals compared are: Villalba, Rey Juan Carlos, and Infanta Elena, and they are compared with 13 directly managed hospitals.

Biomedicine

  • Should you take GLP-1 for longevity? The evidence is exciting, but that’s not the same as proof (https://www.economist.com/science-and-technology/2026/03/13/should-you-take-glp-1-drugs-for-longevity)
  • Detecting oral cancer with a simple photo taken with a mobile phone: the device is still in the prototype phase (https://www.lemonde.fr/sciences/article/2026/03/20/depister-des-cancers-orl-grace-a-une-simple-photo-de-la-bouche-avec-un-smartphone_6672658_1650684.html)
  • Women who go through menopause before age 40 have a higher risk of heart attack. A new study supports this finding (https://www.nytimes.com/2026/03/18/health/menopause-heart-disease-risk-jama.html). Article published in JAMA: https://jamanetwork.com/journals/jamacardiology/fullarticle/2846695?guestAccessKey=3dab6e72-0105-4f54-a20f-4f2edcb06e2f&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031826
  • Immune cells with a hook are better at hunting cancer. Research has developed stronger, longer-lasting, and more precise T lymphocytes to target prostate cancer, paving the way for more potent immunotherapies (https://elpais.com/salud-y-bienestar/2026-03-19/unas-celulas-inmunitarias-reforzadas-con-un-anzuelo-logran-cazar-mejor-el-cancer.html). Access the original article in Science: https://www.science.org/doi/10.1126/science.adx3162
  • Unexpected finding: Tumor cells are addicted to glutathione and use it to grow. Considered a cell damage repairer, it may promote tumor growth and survival. Blocking this antioxidant could be a viable treatment strategy (https://www.diariomedico.com/medicina/oncologia/inesperado-hallazgo-celulas-tumorales-son-adictas-glutation-crecer.html). Access the original article in Nature: https://www.nature.com/articles/s41586-026-10268-2
  • An implantable device enables verbal communication in people with paralysis. A brain-computer interface ‘reads’ the brain instructions a person thinks while using a keyboard and converts them into real text (https://www.diariomedico.com/medicina/neurologia/dispositivo-implantable-permite-comunicacion-verbal-personas-paralisis.html)

Global Health

  • Health and war in Sudan. The humanitarian crisis grows amid international indifference (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00415-0/fulltext)
  • Are microplastics really dangerous to health? New research suggests that the level of microplastics in the environment and in the body may have been overestimated (https://www.bmj.com/content/392/bmj.s421)
  • The US is considering withdrawing HIV aid to Zambia unless it facilitates access to certain minerals. This is according to a draft memo from the State Department (https://www.nytimes.com/2026/03/16/health/zambia-hiv-aid-minerals-trump.html)
  • The WHO warns Argentina that it will be less safe after withdrawing from the organization. The measure was announced a year ago by the government of Javier Milei.
  • (https://www.abc.es/sociedad/oms-advierte-argentina-segura-tras-salida-organizacion-20260319175006-nt.html)

International Health Policy

  • USA
    • United States cuts ties with a major cancer agency. The US withdrawal from the UN may prohibit its scientists from having ties with the International Agency for Research on Cancer (https://www.science.org/content/article/united-states-cutting-ties-influential-global-cancer-agency)
    • Judge suspends Trump Administration vaccine recommendations. A federal judge overturns Robert F. Kennedy, Jr.’s vaccine recommendations, ruling they are not based on science (https://www.lemonde.fr/international/article/2026/03/16/vaccins-aux-etats-unis-un-juge-suspend-la-refonte-des-recommandations-lancee-par-l-administration-trump_6671476_3210.html)
    • Trump’s health policy that Democratic and Republican states are embracing. The policy is to allow tax breaks for companies, instead of helping citizens purchase Obamacare insurance (https://www.politico.com/news/2026/03/15/trump-health-policy-both-parties-bullish-on-00813177)
  • United Kingdom
    • The Covid pandemic brought the UK’s health service to the brink of collapse. The service was ill-prepared and forced professionals to put their lives at risk (https://www.ft.com/content/8b15c3fd-fd23-4957-9152-3befc8b63078?syn-25a6b1a6=1). Access to the UK Covid-19 Inquiry, Module 3: https://covid19.public-inquiry.uk/wp-content/uploads/2026/03/16164422/M3-report-web-accessible-PDF-NO-COMMENTS.pdf
    • King’s Fund response to the Covid-19 Inquiry. According to this think tank, if the crisis were to repeat itself tomorrow, the NHS would be in a worse situation due to longer waiting lists and the problems caused by the closure of NHS England (https://www.kingsfund.org.uk/insight-and-analysis/press-releases/latest-covid-19-inquiry-report)
    • Nuffield Trust response to the Covid-19 Inquiry. The big question, this report says, is whether the NHS is now in a better or worse situation than before the pandemic (https://www.nuffieldtrust.org.uk/news-item/nuffield-trust-response-to-the-covid-inquiry-report-on-healthcare-systems)
  • European Union
    • Opportunities and doubts surrounding the Critical Medicines Act: The Critical Medicines Act is progressing in the EU with the aim of improving the resilience of the pharmaceutical supply chain, although doubts persist about its development in key areas such as public procurement, industrial incentives, and European coordination (https://diariofarma.com/2026/03/19/la-critical-medicines-act-abre-oportunidades-con-dudas-sobre-su-aplicacion-real)
    • The EMA is tightening its surveillance due to the risk of drug shortages caused by the Middle East conflict. The sector is seeking logistical alternatives in Saudi Arabia and Oman to prevent the geopolitical crisis from compromising European citizens’ access to their treatments (https://www.consalud.es/industria/la-ema-activa-la-vigilancia-estrecha-ante-el-riesgo-de-escasez-de-farmacos-por-el-conflicto-en-oriente-medio.html)

National Health Policy

  • Central Government
    • The Ministry of Health will submit guidelines to the Interterritorial Council for reducing waiting lists. The expert working group is finalizing the operational documents that will guide the autonomous communities (https://www.redaccionmedica.com/secciones/parlamentarios/sanidad-elevara-al-interterritorial-las-guias-para-reducir-listas-de-espera-1443)
    • The reform of the LOPS (Law on the Regulation of Health Professions) is open for review. The draft bill will review professional functions and the system of continuing education in the National Health System (https://diariofarma.com/2026/03/17/sanidad-abre-a-consulta-la-reforma-de-la-lops-para-actualizar-el-papel-de-los-profesionales)
  • Regional Governments
    • Catalan model for the care of rare diseases. Experts involved, including those from CatSalut, evaluate the XUEC (Catalan Rare Diseases Units) and highlight their strengths as well as the need for decisions for their efficient implementation (https://www.diariomedico.com/medicina/politica/modelo-atencion-enfermedades-raras-catalan-perla-acabar-pulir.html)
  • Negotiations on the Framework Statute
    • The second week of the strike ends with hundreds of thousands of canceled appointments and no progress between doctors and the Health Ministry (https://elpais.com/sociedad/2026-03-20/la-segunda-semana-de-huelga-termina-con-cientos-de-miles-de-citas-canceladas-y-sin-acercamiento-entre-los-medicos-y-sanidad.html)
    • The Basque Country, Castilla-La Mancha, and the Canary Islands demand independent mediation to stop the doctors’ strike, which has been rejected by the Ministry (https://www.elmundo.es/ciencia-y-salud/salud/2026/03/20/69bd216021efa0822d8b45a3.html)
    • The PP, Vox, PNV, ERC, and Junts parties are now demanding that García negotiate an end to the doctors’ strike. For her part, the minister insists that she is willing to talk, but only with representatives of the Forum of the Medical Profession (https://www.elespanol.com/invertia/observatorios/sanidad/20260321/pp-vox-pnv-erc-junts-exigen-garcia-negocie-final-huelga-medica/1003744177429_0.html)
  • Health Barometer
    • 74% of citizens prefer public healthcare for complex cases, compared to 24% who choose private healthcare. The 061 and 112 emergency services have consolidated their position as the best-rated in the system, according to the 2025 Health Barometer, prepared by the CIS (Spanish Center for Sociological Research) and the Ministry of Health (https://www.elmundo.es/ciencia-y-salud/salud/2026/03/20/69bd42c6e85ece66538b458f.html). Access the latest wave of the Health Barometer (https://www.sanidad.gob.es/estadEstudios/estadisticas/BarometroSanitario/home_BS.htm)
  • MUFACE Crisis
    • The MUFACE crisis worsens with more than 24,000 civil servants moving to the public healthcare system. The number of civil servants has decreased from 1,011,834 to 987,677 between January 31, 2025, and January 31, 2026 (https://www.elespanol.com/invertia/observatorios/sanidad/20260319/crisis-muface-agrava-funcionarios-van-sanidad-publica/1003744175237_0.html)
  • Confidentiality of drug prices
    • Padilla defends the confidentiality of drug prices. The Secretary of State for Health points out that “publishing the net price could create a barrier to access to innovative medicines in Spain.” His position must be understood within the context of the Most Favored Nation Clause promoted by Donald Trump, President of the United States. “Trump has said that he will impose drug prices in his country similar to those of the G7 countries, plus Denmark and Switzerland, that are paying the least. Spain is not part of this group, but Spain’s prices are used as a benchmark by some of these countries, so it all has a cascading effect.” (https://www.diariomedico.com/farmacia/industria/padilla-defiende-confidencialidad-precio-farmacos.html)

Companies

  • International
    • Ozempic about to become generic in India, China, and Canada. Novo Nordisk is about to lose patent protection in those countries (https://www.nytimes.com/2026/03/19/health/ozempic-wegovy-generic-india-china-canada.html)
    • Novartis will pay up to $2.65 billion to Synnovation for an experimental breast cancer drug. The therapy targets the PIK3CA mutation, present in 40% of breast tumors with the worst prognosis (https://www.eleconomista.es/salud-bienestar/noticias/13833766/03/26/novartis-pagara-hasta-2605-millones-a-synnovation-por-un-farmaco-experimental-contra-el-cancer-de-mama.html)
  • National
    • Hospitals in Madrid that operate under concession achieve better results than those under public management, according to a study. Research published in ‘Healthcare’ compares efficiency and quality of care indicators between indirectly managed centers and traditional SERMAS hospitals, always based on officially published data. The concessionary hospitals compared are: Villalba, Rey Juan Carlos, and Infanta Elena, and they are compared with 13 directly managed hospitals. (https://www.elconfidencial.com/salud/2026-03-20/mejores-resultados-en-hospitales-madrilenos-de-gestion-concesional_4323580/). Access the study published in the journal Healthcare: https://www.mdpi.com/2227-9032/14/6/731
    • The generic drug sector is teetering on the brink due to “reckless price reductions,” which jeopardize its viability. “Today, companies face a very dangerous situation: costs are rising and prices are falling,” says Elena Casaus, Secretary General of Aeseg (https://www.elespanol.com/invertia/observatorios/sanidad/20260317/sector-medicamentos-genericos-asoma-abismo-bajadas-temerarias-comprometen-viabilidad/1003744172153_0.html)
    • GSK’s first biosafety laboratory to combat pandemics. The British company has installed the only facility of its kind in a pharmaceutical company at its Spanish subsidiary. The infrastructure cost approximately 5.2 million euros (https://www.elmundo.es/ciencia-y-salud/salud/2026/03/21/69bd63c5e9cf4acb2e8b4594.html)
    • Bayer’s plant in La Felguera, the first in industrial decarbonization. These facilities are set to become the first in the sector in Spain to decarbonize their activity (https://www.elcomercio.es/area-metropolitana-asturias/cuencas/planta-bayer-felguera-pionera-descarbonizacion-industrial-20260313090438-nt.html)

7 days in healthcare (March 9th-15th, 2026)

 

 

Summary

The most impactful health news of the week included:

  • Biomedicine: Changing guidelines on high blood pressure.
  • Global health: Data control and sovereignty concerns lead African countries to reject agreements with the US.
  • International health policy: One-third of Americans have cut spending or resorted to debt for healthcare.
  • National health policy: The Council of Ministers approves the Royal Decree guaranteeing healthcare for undocumented migrants.
  • Companies: The FDA proposes eliminating PK clinical trials (pharmacokinetic tests) to expedite the development of biosimilars.

Biomedicine

  • Changing guidelines on high blood pressure. The trend is to lower the threshold for what is considered hypertension.
  • Certain cancers may be less frequent among vegetarians: prostate, breast, pancreatic, etc. A study in four countries demonstrates a lower risk of cancer in those who abstain from eating meat.
  • Breast cancer surgery can be less invasive without losing effectiveness. The study analyzed the evolution of axillary surgery in more than 17,300 breast cancer patients treated between 2010 and 2021 at 68 accredited centers across Europe.

Global Health

  • Data control and sovereignty concerns are leading African countries to reject agreements with the US being designed under the increasingly criticized America First Global Health Strategy (AFGHS).
  • The human consequences of Epic Fury. The health crisis in Iran and the surrounding Middle East is escalating rapidly, according to Hanan Balkhy, the WHO Regional Director for the Middle East.

International Health Policy

  • One-third of Americans have cut back on healthcare spending or taken out loans. Many Americans are making sacrifices in the face of rising healthcare costs.
  • UK-US agreement on drug prices. Ministers give NICE a role in approvals, despite reservations.

National Health Policy (Spain)

  • The Council of Ministers approves the Royal Decree guaranteeing healthcare for undocumented migrants. It appears the measure was improvised, without assessing the economic impact or the potential pull factor. According to this law, any relative of immigrants can come to Spain and seek medical treatment. It would be important to analyze comparative law to see if this is the case in other European countries. The People’s Party (PP) opposes this Royal Decree.
  • The Community of Madrid is the first autonomous community to support the creation of its own statute for physicians.

Companies

  • International
    • The FDA proposes eliminating PK clinical trials (pharmacokinetic tests) to expedite the development of biosimilars.
  • National
    • Dental visits are the biggest healthcare expense for Spanish families. According to the Spanish Consumers and Users Organization (OCU), households spend an average of €667 annually on dental expenses, making it the largest single healthcare expenditure in the country.

Biomedicine

  • Changing guidelines on high blood pressure. The trend is to lower the threshold for what is considered hypertension. (https://www.nytimes.com/2026/03/14/health/blood-pressure-guidelines-hypertension-dementia.html)
  • The battle for supremacy in weight loss shifts from injections to pills. Novo Nordisk’s Wegovy tablet offers the Danish manufacturer the opportunity to compete with Lilly (https://www.ft.com/content/6e805306-5195-40d5-b1a2-fe2700d7721b)
  • Certain cancers may be less common among vegetarians: prostate, breast, pancreatic, etc. A study conducted in four countries shows a lower risk of cancer in those who abstain from eating meat (https://www.lemonde.fr/planete/article/2026/03/11/prostate-sein-pancreas-certains-cancers-seraient-moins-frequents-chez-les-vegetariens_6670539_3244.html)
  • Wegovy is associated with a higher risk of “eye stroke” than other anti-obesity drugs. An FDA adverse effects analysis reveals that the chances of developing ischemic optic neuropathy are five times higher with this drug than with Ozempic. All signs point to high doses (https://www.abc.es/salud/wegovy-asocia-mayor-riesgo-infarto-ocular-farmacos-20260310042620-nt.html)
  • Breast cancer surgery can be less invasive without losing effectiveness. The study analyzed the evolution of axillary surgery in more than 17,300 breast cancer patients treated between 2010 and 2021 in 68 accredited units across Europe (https://www.elmundo.es/ciencia-y-salud/salud/2026/03/10/69b00b5621efa08e578b456e.html)
  • The solution to fertility problems may lie in the brain. The RANK protein acts as a key mediator in cell-to-cell communication (https://www.elconfidencial.com/salud/2026-03-12/relacion-celulas-cerebro-fertilidad_43)

Global Health

  • Global health in an era of US extraction, with the destruction of global health by 2025. The United States is targeting African countries with high-cost bilateral agreements. Extraction is a word Trump likes (https://www.bmj.com/content/392/bmj.s394?nbd_source=adestra&nbd=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)
  • Iran: WHO calls For the protection of healthcare workers. Healthcare workers and facilities are under fire in the Middle East conflict, warn health leaders and charities. (https://www.bmj.com/content/392/bmj.s445?nbd_source=adestra&nbd=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)
  • The human consequences of Epic Fury. The health crisis in Iran and the surrounding Middle East is escalating rapidly, according to Hanan Balkhy, the WHO Regional Director for the Middle East (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00497-6/fulltext).
  • Peace, let it come quickly. War is bad for health; how can we avoid a war that is being chosen? (https://www.bmj.com/content/392/bmj.s480)
  • Data control and sovereignty concerns are leading African countries to reject agreements with the US designed under the increasingly criticized American First Global Health Strategy (AFGHS) (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00509-X/fulltext)

International Health Policy

  • USA
    • A new wave of disruptors is trying to control American healthcare. American healthcare is very expensive and generates significant user dissatisfaction. This has led many large companies, such as Google, IBM, Amazon, and others, to experience major failures in trying to “fix” the system. In these changing times, AI is looking to play a role in this regard, and the ChapGPT is playing an increasingly important part (https://www.economist.com/business/2026/03/10/a-new-wave-of-disrupters-takes-on-american-health-care)
    • Two states (Vermont and Indiana) stand out for their soaring hospital prices. Since 2000, hospital prices have risen 250%, double the rate of healthcare spending and triple the rate of inflation (https://www.economist.com/united-states/2026/03/12/two-very-different-states-take-aim-at-soaring-hospital-prices)
    • One-third of Americans have cut back on healthcare spending or taken out loans. Many Americans are making sacrifices in the face of rising healthcare costs (https://www.nytimes.com/2026/03/12/health/health-costs-cutting-back.html)
    • The FDA opens the door to cigarettes with more flavors, such as mint, coffee, or tea, to attract more adults (https://www.nytimes.com/2026/03/09/health/fda-e-cigarettes-flavors.html)
    • A Trump memo attacks the Cuban doctors program. The US government is trying to hinder the Cuban doctors program abroad (https://www.politico.com/news/2026/03/13/cuban-doctors-us-pressure-00827683)
  • United Kingdom
    • New deficits in NHS funding. Many of the trusts are in deficit, meaning spending exceeds the budget (https://www.kingsfund.org.uk/insight-and-analysis/data-and-charts/nhs-trusts-deficit)
    • UK-USA agreement on drug prices. Ministers give NICE a role in approvals, despite reservations (https://www.bmj.com/content/392/bmj.s442?nbd_source=adestra&nbd=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)
  • France
    • More than 20,000 people from over 65 people died from falls in 2024. Between 2019 and 2024, the number of deaths from falls rose by 18% (https://www.lemonde.fr/societe/article/2026/03/13/plus-de-20-000-personnes-de-plus-de-65-ans-sont-mortes-a-cause-d-une-chute-en-2024-un-phenomene-en-augmentation-et-encore-inexplique_6671008_3225.html)

National Health Policy

  • Central Government
    • The Council of Ministers approves the Royal Decree guaranteeing healthcare for undocumented migrants (https://www.elmundo.es/ciencia-y-salud/salud/2026/03/10/69afd778e9cf4a47378b45a8.html)
    • The Ministry of Health rules out an audit of the controversial MIR exam, but will allocate €10.2 million to its management and digitization (https://www.elconfidencial.com/salud/2026-03-10/10-2-millones-gestion-mir-ministerio-de-sanidad_4317899/)
  • Regional Governments
    • The Canary Islands approves the 2026-2031 Health Plan with 49 priority areas (https://www.consalud.es/autonomias/canarias/canarias-aprueba-el-plan-de-salud-2026-2031.html)
    • The Parliament of Cantabria sets a maximum of 15 days for delivering the results of biopsies suspected of being cancerous (https://diariofarma.com/2026/03/12/el-parlamento-de-cataluna-exige-retirar-el-proyecto-de-ley-de-gestion-publica-por-invadir-competencias)
    • The initial project for the future Girona health campus has been selected (https://www.diariomedico.com/medicina/politica/seleccionado-proyecto-inicial-futuro-campus-salud-girona.html)
    • Asturian healthcare will subject the specialties with the longest waiting lists to an audit (https://www.elcomercio.es/asturias/sanidad-asturias-especialidades-listas-espera-auditoria-20260310201008-nt.html)
    • Galicia’s new strategy against rare diseases (https://gacetamedica.com/politica/enfermedades-raras-galicia-acceso-precoz/)
  • Negotiations on the Framework Statute
    • The Community of Madrid, the first autonomous community to support the creation of its own statute for doctors (https://www.elmundo.es/ciencia-y-salud/salud/2026/03/12/69b2f4a2e4d4d8801f8b45b9.html)
    • Doctors deny the existence of the agreement defended by Mónica García and call her proposal “poor and ridiculous” (https://www.larazon.es/sociedad/medicos-niegan-que-exista-acuerdo-que-defiende-monica-garcia-califican-propuesta-pobre-ridicula_2026031369b414cfd489bf782e18fb37.html)
  • Public Management Law
    • The Parliament of Catalonia demands the withdrawal of the Public Management Law (https://diariofarma.com/2026/03/12/el-parlamento-de-cataluna-exige-retirar-el-proyecto-de-ley-de-gestion-publica-por-invadir-competencias)
    • The Basque Nationalist Party (PNV) and Together for Catalonia (Junts) avoid supporting a motion on public management of the National Health System (SNS) proposed by the Spanish Socialist Workers’ Party (PSOE). (https://diariofarma.com/2026/03/08/pnv-y-junts-evitan-apoyar-una-mocion-sobre-gestion-publica-del-sns-del-psoe)
  • Royal Decree on healthcare for undocumented immigrants
    • The PP opposes it. It warns that the measure is being taken without planning and in a context of overburdened public healthcare professionals (https://diariofarma.com/2026/03/10/criticas-del-pp-al-decreto-de-cobertura-universal-convierte-la-irregularidad-en-un-derecho)
  • Study on oral health in Spain
    • White Paper on Oral Health from the General Council of Dentists. It analyzes the evolution over a quarter of a century: 2000-2025 (https://consejodentistas.es/wp-content/uploads/2026/03/2026.02.09-Libro-blanco-salud-oral-2025-1.pdf)

Companies

  • International
    • The boom in counterfeit obesity drugs. Due to high prices, lack of insurance coverage, and the desire to lose weight, counterfeit medications are proliferating, generating health concerns. (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00461-7/fulltext)
    • Sales of the obesity drug Mounjaro catapult Lilly to the top spot as the world’s leading pharmaceutical company in revenue (https://www.elespanol.com/invertia/observatorios/sanidad/20260313/ventas-farmaco-obesidad-mounjaro-catapultan-eli-lilly-primera-pharma-mundial-ingresos/1003744166443_0.html)
    • The FDA is considering eliminating PK clinical trials (pharmacokinetic tests) to expedite the development of biosimilars (https://diariofarma.com/2026/03/09/la-fda-plantea-la-eliminacion-de-estudios-clinicos-pk-para-agilizar-el-desarrollo-de-biosimilares)

 

 

7 days in healthcare (March 2nd-8th, 2026)

 

 

Summary

The most impactful health news stories of the week were:

  • Biomedicine: The immunotherapy that revolutionized cancer treatment has a dark side.
  • Global health: Gender equality and equity: essential for health and society.
  • International health policy: Growing control of private equity (PE) firms in American healthcare.
  • National health policy: Feijóo (PP) addresses a letter to doctors, following the conflict over the Framework Statute.
  • Companies: Novo Nordisk’s illness as a company.

Biomedicine

  • The immunotherapy that revolutionized cancer treatment has a dark side: 63 complications linked to high mortality. According to pharmacovigilance data from more than 290,000 patients in the USA and the WHO database.
  • Blood tests for cancer are proliferating. Do they really work? Their manufacturers say they can detect dozens of types of cancer. But many scientists say they may fail to diagnose some cancers or provide an incorrect diagnosis. There are more than 40 cancer screening tests in development, and some are already on the market.
  • The shingles vaccine: promising side effects against dementia. Immunization against the virus has been shown to delay Alzheimer’s.

Global Health

  • Gender equality and equity: essential for health and society. The term gender equality has been downplayed by the Trump Administration. A global study shows that 608 million girls over the age of 15 have been exposed to intimate partner violence, and more than 1 billion boys have experienced sexual violence during childhood. It remains a key issue, according to The Lancet.
  • Global warming has accelerated significantly. The latest data confirm the acceleration of warming.

International Health Policy

  • The transformation of American medicine by private equity (PE) firms. These companies have gained increasing control over healthcare infrastructure. PE investors promise to eliminate inefficiencies in America’s fragmented healthcare markets, increase investment, and exploit economies of scale. However, growing evidence shows that PE companies have created access difficulties for rural populations, the elderly, low-income communities, marginalized groups, and ethnic minorities.
  • Trends among primary care physicians in the USA: dissatisfaction, stress, and burnout. This is very prevalent in primary care, but the causes are poorly understood. In an international study, burnout among American primary care physicians was 42%, compared to only 18% in Switzerland and 12% in the Netherlands.
  • Monitoring pollution should be part of governments’ work in the fight against cancer, according to the new European Code Against Cancer.

National Health Policy (Spain)

  • Countdown to the Digital Health Law, which aims to regulate interoperable and accessible digital health records throughout the country and the European Union.
  • Feijóo’s (PP) letter to doctors. It is extremely commendable that the PP President met with the Forum of the Medical Profession and with the strike committee regarding the Framework Statute. However, his advisors could surely have put more effort into the letter’s content, moving beyond the specific union demands and focusing their solution on a more defined and explicit healthcare policy, which is lacking in the letter.
  • The IDIS Foundation presents objections to the Draft Law on Public Management and Integrity of the National Health System and denounces it as a frontal attack on “public/private collaboration in healthcare.”

Companies

  • International
    • The decline of Novo Nordisk as a company offers painful lessons. It went from being the company with the largest market capitalization in Europe to suffering a collapse in its value, and in the field of obesity, it is now second only to Lilly.
  •  National
    • Aspirin, Frenadol, Ventolin, and Almax, top-selling drugs “made in Spain.” Spain is home to 111 pharmaceutical plants for human use. Bayer, GSK, Pfizer, Novartis, Lilly, Almirall, Faes Farma, and Merck have strategic plants in the country that export worldwide.

Biomedicine

  • Blood tests for cancer are proliferating. Do they really work? Their manufacturers say they can detect dozens of types of cancer. But many scientists say they may miss some cancers or give a false positive. There are more than 40 cancer screening tests in development and some already on the market (https://www.nature.com/articles/d41586-026-00661-2)
  • Stem cells offer a powerful treatment for frailty. Older people with frailty, which affects a quarter of those over 50, showed improved resilience after a single dose of stem cells (https://www.nature.com/articles/d41586-026-00584-y)
  • Users of weight-loss injections have a lower risk of alcohol and drug addiction. Researchers find that GLP-1 users are less likely to develop substance use disorders (https://www.ft.com/content/899f2d49-af16-4b68-a33a-9edf294678c8)
  • The immunotherapy that revolutionized cancer treatment has a dark side: 63 complications linked to high mortality. This is according to pharmacovigilance data from more than 290,000 patients in the USA and the WHO database (https://www.elconfidencial.com/salud/2026-03-02/la-inmunoterapia-que-revoluciono-el-cancer_4312734/). Access the original article: https://www.pnas.org/doi/abs/10.1073/pnas.2427234123
  • Gene therapy shows very promising results against Dravet syndrome: it reduces epileptic seizures by 91%. The treatment is still experimental (https://www.elmundo.es/ciencia-y-salud/salud/2026/03/05/69a82917e4d4d8c0378b456e.html). Access the original article: https://www.nejm.org/doi/full/10.1056/NEJMoa2506295
  • Scientists decode the “brain’s pipes”: cerebrospinal fluid, key to understanding and fighting tumors. The results of a study led by the National Center for Genomic Analysis (CNAG) open new avenues for developing personalized therapies for patients with central nervous system tumors (https://www.elmundo.es/ciencia-y-salud/salud/2026/03/06/69aaf8e3fc6c8357058b4570.html)
  • Immunotherapy, which is curing cancer, is now targeting Alzheimer’s. A study in ‘Science’ transfers the promising anti-cancer technology to astrocytes, enabling them to act as a precision cleaning service in the brain (https://www.abc.es/salud/cancer-alzheimer-inmunoterapia-nueva-arma-20260305200540-nt.html)
  • The shingles vaccine: promising side effects against dementia. Immunization against the virus has been shown to delay Alzheimer’s (https://elpais.com/salud-y-bienestar/2026-03-02/la-vacuna-del-herpes-zoster-prometedores-efectos-secundarios-contra-la-demencia.html)

Global Health

  • Gender equality and equity: essential for health and society. The term gender equality has been downplayed by the Trump Administration. A global study shows that 608 million girls over the age of 15 have been exposed to intimate partner violence and more than 1 billion boys have experienced sexual violence during childhood (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00456-3/fulltext)
  • Bangladesh’s ambitious health plan. The new government has promised to prioritize health in its policies (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00458-7/fulltext)
  • Botswana’s fight against HIV. With cuts in international aid, Botswana has been left without HIV control programs (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02585-1/fulltext)
  • Global warming has accelerated significantly. The latest data confirm the acceleration of warming (https://onlinelibrary.wiley.com/doi/abs/10.1029/2025GL118804)

International Health Policy

  • USA
    • The transformation of American medicine by private equity (PE) firms. These firms have gained increasing control over healthcare infrastructure. PE investors promise to eliminate inefficiencies in fragmented American healthcare markets, increase investment, and exploit economies of scale. However, growing evidence shows that PE firms have resulted in access difficulties for rural populations, the elderly, low-income communities, marginalized groups, and ethnic minorities (https://www.nejm.org/doi/full/10.1056/NEJMp2415615).
    • Trends among primary care physicians in the USA: dissatisfaction, stress, and burnout. This is very prevalent in primary care, but the causes are poorly understood. In an international study, burnout among US primary care physicians was 42%, compared to only 18% in Switzerland and 12% in the Netherlands (https://www.healthaffairs.org/doi/10.1377/hlthaff.2025.00880)
  • China
    • China hopes IVF can improve its birth rates. The number of IVF treatment cycles in China grew from 236,000 in 2013 to more than 1.1 million in 2019 (https://www.economist.com/china/2026/03/01/china-hopes-ivf-can-slow-its-baby-bust)
  • United Kingdom
    • How GPs (primary care physicians) are using AI. In a survey of 2,108 British GPs, 598 (28%) say they use AI in their clinical practice (https://www.nuffieldtrust.org.uk/research/how-are-gps-using-ai-insights-from-the-front-line)
    • Why does England have GPs without jobs, while people can’t get an appointment? The article analyzes how many doctors may not be able to find positions in Primary Care, while unmet demand increases (https://www.nuffieldtrust.org.uk/resource/why-does-england-have-unemployed-gps-when-patients-can-t-get-gp-appointments)
  • France
    • France authorizes an injectable preventive treatment for HIV, a move welcomed by numerous experts and associations (https://www.lemonde.fr/societe/article/2026/02/26/vih-la-france-autorise-enfin-un-traitement-preventif-injectable_6668379_3224.html)
  • European Union
    • Monitoring pollution should be part of governments’ work in the fight against cancer (https://www.theguardian.com/environment/2026/mar/06/tackle-air-pollution-cut-cancer-rates-scientists). Access the European Code Against Cancer: https://cancer-code-europe.iarc.who.int

National Health Policy

  • Central Administration
    • Countdown to the Digital Health Law, which aims to regulate interoperable and accessible digital health records throughout the country and the European Union (EU) (https://www.consalud.es/politica/ministerio-sanidad/cuenta-atras-para-la-ley-de-salud-digital-sanidad-espera-su-aprobacion-definitiva-este-mismo-ano.html)
    • The Ministry of Health expects the Royal Decree on Health Technology Assessment to be approved before April, designed to lay the foundations for a new regulatory framework for the assessment of these technologies in Spain (https://elglobalfarma.com/politica/sanidad-rd-evaluacion-tecnologias-sanitarias-aprobacion-abril/)
  • Regional Administrations
    • The Catalan budget proposal increases investment in health. The government’s forecasts propose allocating €13.84 billion to healthcare, with Primary Care accounting for 31% of the spending (https://diariofarma.com/2026/03/01/el-proyecto-de-presupuestos-catalanes-elevan-la-inversion-en-salud-en-2-428-millones)
    • The Balearic Islands health service is joining the EU-Patient Summary to improve emergency care in Europe. Healthcare professionals in other European countries will be able to access data such as allergies, active medications, and relevant pathologies (https://www.consalud.es/autonomias/baleares/el-servicio-de-salud-de-baleares-se-integra-en-eu-patient-sumary-para-mejorar-la-atencion-de-urgencia-en-europa.html)
    • Madrid pharmacies strengthen their healthcare role (https://diariofarma.com/2026/02/27/la-farmacia-madrilena-impulsa-su-rol-sanitario-con-un-nuevo-modelo-modelo-de-gestion-de-servicios)
    • A virtual assistant in Asturias will now be available for scheduling medical appointments at health centers. The ordeal of constantly busy health center phones in Asturias is over. For now, however, this service is only available to residents of the Nalón Valley. They will be the privileged few who will no longer have to wait for someone to answer the phone to schedule an appointment with their doctor. “Noa” arrives, a virtual assistant that never communicates and will answer calls 24 hours a day, 365 days a year (https://www.lne.es/cuencas/2026/03/02/calvario-contactar-telefono-centros-salud-127451276.html)
  • Negotiations on the Framework Statute
    • Feijóo’s letter to doctors (https://www.cesm.org/wp-content/uploads/2026/03/CARTA-PRESIDENTE-FEIJOO-A-LOS-MEDICOS-1.pdf)
    • The Ministry of Health and the Forum of the Medical Profession reach an agreement to try to avoid the strike. The Forum includes union representatives (CESM) and professional associations and scientific societies. Mónica García’s Ministry seeks to smooth things over with this rapprochement, but the Strike Committee has not called off the strikes (https://www.elmundo.es/ciencia-y-salud/salud/2026/03/05/69a98bf7e9cf4a054d8b458f.html)
    • The medical unions CESM and Amyts temper optimism in the healthcare sector: “There is no agreement” (https://www.elmundo.es/ciencia-y-salud/salud/2026/03/06/69aaedb0e85ece60688b45b3.html)
  • Public Management Law
    • The IDIS Foundation presents objections to the Draft Law on Public Management and Integrity of the National Health System and denounces it as a frontal attack on “public/private collaboration in healthcare” (https://isanidad.com/363189/idis-lamenta-que-el-anteproyecto-de-ley-de-gestion-publica-supone-un-ataque-frontal-a-la-colaboracion-publica-privada/)
  • MIR Exam
    • The government will reform the MIR exam after the exam with the most “errors”: a record number of annulled questions, resignations, suspicions of fraud, and delays in procedures (https://www.elmundo.es/ciencia-y-salud/salud/2026/03/07/69ac4d4a21efa0ec6e8b456d.html)
    • 99.19% of applicants who took the Specialized Health Training exams passed. (https://www.elmundo.es/ciencia-y-salud/salud/2026/02/27/69a1ff2de85ece005b8b4589.html)

Companies

  • International
    • Bayer suffers multimillion-dollar losses due to lawsuits related to glyphosate (https://elpais.com/economia/2026-03-04/bayer-sufre-perdidas-millonarias-por-las-demandas-relacionadas-con-el-glifosato.html)
    • Permira freezes the sale of Neuraxpharm as it seeks a valuation exceeding €3.5 billion (https://www.elconfidencial.com/empresas/2026-03-05/permira-enfria-venta-neuraxpharm-ofertas-inferiores_4314494/)
    • The Novo Nordisk crisis as a company offers painful lessons. It went from being the company with the largest market capitalization in Europe to suffering a collapse in its value, and in the field of obesity, it’s second only to Lilly (https://cincodias.elpais.com/opinion/2026-03-04/la-enfermedad-de-novo-nordisk-ofrece-dolorosas-lecciones.html)
  • National
    • Miranza increases its revenue by 16% in 2025 and accelerates its expansion in Portugal. The ophthalmology group surpasses €128 million in revenue, increases its surgical activity, and invests in AI and R&D (https://www.consalud.es/salud35/nacional/miranza-eleva-un-16-su-facturacion-en-2025-y-acelera-su-expansion-a-portugal.html)
    • Novo Nordisk announces price reductions for “Ozempic” and “Wegovy” in Spain. The price will decrease by up to 17.6% for the highest dose of “Wegovy,” to €223.64. Ozempic and Rybelsus, with very restrictive NHS funding, also see price drops (https://www.diariomedico.com/medicina/empresas/novo-nordisk-anuncia-bajada-precios-ozempic-wegovy-espana.html)
    • Oximesa acquires Esteve Teijin Healthcare and strengthens its home respiratory therapy services, following approval by the CNMC (https://www.consalud.es/salud35/nacional/oximesa-adquiere-esteve-tejin-healthcare-y-refuerza-sus-servicios-de-terapias-respiratorias-domiciliarias-en-la-peninsula.html)
    • The General Council of Dentists demands answers regarding the reasons for the €40 million bailout of Vivanta. The General Council of Dentists demands transparency regarding the €40 million public bailout granted to Vivanta, while thousands of iDental patients remain without treatment solutions or reimbursement of their payments (https://www.consalud.es/dentalia/clinicas/el-consejo-de-dentistas-reclama-las-razones-del-rescate-a-vivanta-costo-40-millones-de-dinero-publico.html)
    • Aspirin, Frenadol, Ventolin, and Almax, best-selling drugs “made in Spain.” Spain is home to 111 pharmaceutical plants for human use. Bayer, GSK, Pfizer, Novartis, Lilly, Almirall, Faes Farma, and Merck have strategic plants in the country that export worldwide (https://www.expansion.com/empresas/industria/2026/03/06/69a49877468aeb955f8b457e.html)
    • The dental business accelerates its digitalization with the arrival of AI and 3D printers (https://cincodias.elpais.com/extras/2026-03-04/el-negocio-dental-acelera-su-digitalizacion-con-la-llegada-de-la-ia-y-las-impresoras-3d.html)
    • Grifols acquires Canadian Plasma Resources and takes a key step in its diversification. As part of its strategy to diversify plasma sources, Grifols is moving forward with its growth plans in Canada, one of the group’s strategic markets (https://www.eleconomista.es/salud-bienestar/noticias/13811727/03/26/grifols-compra-canadian-plasma-resources-y-da-un-paso-clave-en-su-diversificacion.html)

7 days in healthcare (February 23rd-March 1st, 2026)

 

Summary

The week’s most impactful health news stories were:

  • Biomedicine: An mRNA vaccine shows potential in triple-negative breast cancer.
  • Global Health: Why does the US vaccine recall not only affect the US?
  • International Health Policy: Two prosecutors and 13 states oppose RFK, Jr.’s anti-vaccine policies.
  • National Health Policy: Feijóo (PP) is open to considering a specific statute for doctors.
  • Business: Pharmaceutical companies are building bridges to the patent precipice.

Biomedicine

  • An mRNA vaccine shows potential in triple-negative breast cancer. A preliminary trial with 14 patients with triple-negative breast cancer indicates that it triggers robust immune responses safely and lastingly.
  • A new single-pill treatment for HIV promises a solution for survivors of this disease.
  • The discovery of genetic variants that predispose individuals to smoking opens new therapeutic avenues against tobacco addiction. Smoking is responsible for millions of deaths worldwide each year. Although its harmful effects are widely known, addiction makes quitting smoking a difficult task, and available treatment options remain limited.

Global Health

  • Why does the US withdrawal of vaccines not only affect the US? The modification of the childhood vaccination schedule by the Centers for Disease Control and Prevention (CDC) last January will foreseeably have public health implications for the American population, but the consequences may extend further. The CDC removed six of the 17 vaccines previously recommended for this population segment: the flu and COVID-19 vaccines for children, as well as those for rotavirus, meningitis, hepatitis A, and hepatitis B. These vaccines can still be administered in the US, but only after consultation with a specialist, that is, under the shared clinical decision-making approach coined by the US administration.

International Health Policy

  • Two Attorneys General and 13 States Oppose RFK Jr.’s Anti-Vaccine Policies. A coalition of 14 state attorneys general, led by California Attorney General Rob Bonta and Arizona Attorney General Kris Mayes, has filed a multistate lawsuit against the Trump Administration for the “unprecedented” changes to the childhood immunization schedule.
  • Robert F. Kennedy Jr.: A Year of Failures. Serious errors in vaccine policy, nutritional recommendations, and cuts to research.
  • Europe Wants to Guarantee Diagnosis of Rare Diseases within 12 Months. The European Parliament is finalizing an initiative to create a binding framework for these illnesses. The current average for a diagnosis exceeds four years.

National Health Policy (Spain)

  • Feijóo (PP) is open to considering a specific statute for doctors. He has conveyed to physicians that he supports the need for them to have their own negotiating body. The unions’ virtual monopoly on negligence with the Administration, contrary to the consideration of the “professionalism” of doctors and other professionals.
  • In its submissions to the Ministry, the FADSP (Federation of Associations for the Defense of Public Health) states that the safeguards established in the Draft Law on Public Management to prevent the “privatization” of the National Health System (SNS) seem insufficient. Submissions are also expected from the IDIS Foundation and ASPE, most likely taking a very different stance, given the attack that the Draft Law on Public Management represents on public/private partnerships in healthcare, proposing a change along “Podemos-style” lines to the General Health Law.

Companies

  • International
    • Pharmaceutical companies are building bridges to the patent precipice. Only 10% of the drug revenues of the top 20 firms will still have patent protection in a decade.
  • National News
    • FENIN calls for institutional support to increase medical technology manufacturing in Spain. Fenin has presented the study ‘Medical Technology Manufacturers in Spain’, which offers a comprehensive overview of the sector’s contribution to the national economy.

Biomedicine

  • Grail’s cancer detection test fails in a major study. The test seemed promising for avoiding late cancer diagnoses, but this has not been confirmed in a large clinical trial (https://www.nytimes.com/2026/02/20/health/cancer-detection-test-grail.html)
  • Longevity and wellness are driving the promotion of miracle cures, never tested on humans. Health influencers play a significant role in this (https://www.ft.com/content/0f682ce3-b0e7-46bc-8d1a-e288f24ad8de)
  • A new one-time HIV pill promises a solution for survivors of the disease (https://www.ft.com/content/4fe55a54-0d89-4dca-9724-cc22044dc0fa). Original article in The Lancet: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00307-7/fulltext
  • Vegetarians have a lower risk of five cancers, including breast, prostate, and kidney cancer (https://www.ft.com/content/ce5a1436-51a8-4d3c-9eaa-4c8644bacf83)
  • The discovery of genetic variants that predispose individuals to smoking opens new therapeutic avenues for combating tobacco addiction. Smoking is responsible for millions of deaths worldwide each year. Although its harmful effects are widely known, addiction makes quitting smoking a difficult task, and the available treatment options remain limited (https://elpais.com/expres/2026-02-25/el-hallazgo-de-variantes-geneticas-que-predisponen-a-fumar-abre-nuevas-vias-terapeuticas-contra-la-adiccion-al-tabaco.html)
  • The first vaccine to prevent four cancers: colon, rectum, endometrium, and stomach. A Spanish researcher is leading pioneering research against Lynch syndrome at the MD Anderson Cancer Center in Houston (https://www.abc.es/salud/primera-vacuna-prevenir-cuatro-tumores-colon-recto-20260214042656-nt.html)
  • A living drug has eliminated tumors in mice with pancreatic, ovarian, or kidney cancer (https://elpais.com/salud-y-bienestar/2026-02-26/un-farmaco-viviente-logra-eliminar-los-tumores-de-ratones-con-cancer-de-pancreas-ovario-o-rinon.html). Access the original article: https://www.science.org/doi/10.1126/science.adv7378
  • An mRNA vaccine shows potential in triple-negative breast cancer. A preliminary trial with 14 patients with triple-negative breast cancer indicates that it triggers robust immune responses safely and lastingly (https://www.diariomedico.com/medicina/oncologia/vacuna-arnm-muestra-potencial-cancer-mama-triple-negativo.html)
  • When ChatGPT becomes the medical record in direct-to-consumer care. Interesting analysis from Health Affairs magazine (https://www.healthaffairs.org/do/10.1377/forefront.20260210.132574/full/)

Global Health

  • Africa lags behind in surgeries that prevent the leading cause of blindness. Three out of four people on the continent do not have access to cataract surgery. Experts warn that there are also gaps in the intervention for glaucoma and eye injuries in children (https://elpais.com/planeta-futuro/2026-02-23/africa-a-la-cola-de-las-cirugias-que-previenen-la-principal-causa-de-ceguera-nadie-deberia-perder-la-vista-por-cataratas.html)
  • The UN proposes a roadmap for Bolivia to reverse its high maternal mortality rates. The United Nations Population Fund (UNFPA) presented a strategy on Tuesday for Bolivia to control and reduce maternal mortality (https://www.abc.es/espana/propone-ruta-bolivia-revierta-altos-ndices-mortalidad-20260225031647-vi.html)
  • Why does the US vaccine recall not only affect the US? The modification of the childhood vaccination schedule by the Centers for Disease Control and Prevention (CDC) last January will predictably have public health implications for the American population, but the consequences may extend further. The CDC removed six of the 17 vaccines previously recommended for this population segment: the flu and COVID-19 vaccines for children, as well as those for rotavirus, meningitis, hepatitis A, and hepatitis B. These vaccines can still be administered in the U.S., but only after consultation with a specialist, that is, under the shared clinical decision-making approach coined by the U.S. administration. (https://www.diariomedico.com/medicina/medicina-preventiva/retirada-vacunas-eeuu-afecta-eeuu.html)

International Health Policy

  • USA
    • The growing success of Medicare drug negotiations, which will achieve significant discounts on 15 new medications in 2027 (https://www.nejm.org/doi/full/10.1056/NEJMp2517584)
    • The new US dietary guidelines: a recipe for worse health. Poor adherence to scientific evidence (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00300-4/fulltext)
    • Federal reforms of PBMs. There is agreement between both parties, Democrats and Republicans, for this reform (https://www.healthaffairs.org/do/10.1377/forefront.20260223.563817/full/)
    • Robert F. Kennedy, Jr., a year of missteps. Serious errors in vaccine policy, nutritional recommendations, and research cuts (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00414-9/fulltext)
    • Obamacare’s new plans could increase family deductibles by up to $31,000, potentially raising bills for families (https://www.nytimes.com/2026/02/26/health/obamacare-health-insurance-rollbacks.html)
    • Two attorneys general and 13 states oppose RFK Jr.’s anti-vaccine policies. A coalition of 14 state attorneys general, led by California Attorney General Rob Bonta and Arizona Attorney General Kris Mayes, has filed a multistate lawsuit against the Trump Administration over “unprecedented” changes to the childhood vaccination schedule. (https://gacetamedica.com/politica/fiscales-guerra-politicas-antivacunas-kennedy-jr-eeuu/)
  • France
    • The end-of-life bill has been approved by the Congress and returns to the Senate, along with the bill on palliative care (https://www.lemonde.fr/societe/article/2026/02/25/fin-de-vie-l-assemblee-nationale-approuve-la-proposition-de-loi-instaurant-un-droit-a-l-aide-a-mourir-le-texte-transmis-au-senat_6668257_3224.html)

National Health Policy

  • Central Government
    • Public comment periods for the Draft Bills on Patient Participation and Public Management and Integrity of the National Health System. The deadline for both drafts is March 4, 2026 (https://www.sanidad.gob.es/normativa/audiencia/home.htm)
  • Regional Governments
    • Andalusia creates specialist research categories for physicians and nurses. The Minister of Health, Antonio Sanz, highlights that “it is the first autonomous community to integrate clinical research into the heart of the healthcare system” (https://www.consalud.es/autonomias/andalucia/andalucia-crea-las-categorias-de-facultativo-y-enfermera-especialistas-clinicos-investigadores.html)
    • Valdecilla Hospital activates a unit for Rare Diseases. With funding from European and regional sources, the Rare Diseases Unit at Valdecilla Hospital will integrate 12 medical disciplines (https://diariofarma.com/2026/02/26/valdecilla-activa-en-marzo-su-nueva-unidad-de-ee-rr-en-la-que-realizara-2-000-atenciones-anuales)
    • Alfonso X University has set a date for admission of medical and nursing students in Oviedo. UAX sets the goal of “building a hub for job creation and talent retention” linked to the health sciences sector in Asturias (https://www.elcomercio.es/oviedo/universidad-alfonso-fecha-proceso-admision-estudiantes-medicina-20260226153026-nt.html)
    • The HUCA (Central University Hospital of Asturias) has interminable delays in dermatology; they postpone the review of an oncological lesion for a year (https://www.lne.es/asturias/2026/03/01/efectos-demoras-interminables-dermatologia-huca-127401441.html)
  • Problems with the Framework Statute
    • Feijóo (PP) is open to considering a specific Statute for doctors; he has conveyed to physicians that he defends the need for them to have a framework for negotiation (https://www.elespanol.com/invertia/observatorios/sanidad/20260227/feijoo-pp-ofrece-valorar-estatuto-marco-exclusivo-medicos-hara-propuesta-proxima-semana/1003744147664_0.html)
    • Mónica García speaks out again against a specific statute for doctors. The Minister of Health, Mónica García, has stated that she sees no need for doctors to have their own statute because “their specificities fit within a common statute” (https://www.abc.es/espana/mnica-garca-estatuto-propio-mdicos-solo-servira-20260223135741-vi.html).
  • Public Management Law
    • In its submissions to the Ministry, the FADSP (Federation of Associations for the Defense of Public Healthcare) states that the safeguards established in the Draft Law on Public Management to prevent the “privatization” of the National Health System (SNS) seem insufficient (https://cronicasanitaria.es/2026/02/27/fadsp-considera-que-la-ley-para-limitar-la-colaboracion-publico-privada-en-sanidad-no-garantiza-un-blindaje-suficiente/). Access to FADSP’s allegations: https://fadsp.es/alegaciones-fadsp-ley-sns/

Companies

  • International
    • Gilead heats up biotechnology: buys Arcellx for €6.6 billion to strengthen its position in cancer treatment (https://cincodias.elpais.com/companias/2026-02-23/gilead-calienta-la-biotecnologia-compra-arcellx-por-6600-millones-para-reforzarse-en-los-tratamientos-de-cancer.html)
    • The Novo Nordisk Foundation supports quantum computing beyond Denmark (https://www.ft.com/content/8896a881-5246-4bfd-a989-8e6612026bcf)
    • Novo Nordisk’s stock price plummets after trials of its new obesity drug (https://www.vozpopuli.com/sanitatem/novo-nordisk-se-desploma-en-bolsa-tras-los-ensayos-de-su-nuevo-medicamento-contra-la-obesidad.html)
    • Why pharmaceutical products have not been affected by Trump’s tariffs, an analysis by David Cantarero (IDIVAL) (https://elglobalfarma.com/politica/por-que-productos-farmaceuticos-libran-arancel-trump/)
    • Pharmaceutical companies are buying bridges to the patent precipice. Only 10% of the pharmaceutical revenues of the top 20 companies will still be protected in a decade (https://cincodias.elpais.com/opinion/2026-02-25/las-farmaceuticas-compran-puentes-para-el-precipicio-de-las-patentes.html)
  • National
    • FENIN calls for institutional support to increase medical technology manufacturing in Spain. Fenin has presented the study ‘Medical Technology Manufacturers in Spain’, which offers a comprehensive overview of the sector’s contribution to the national economy (https://www.diariomedico.com/medicina/empresas/fenin-reclama-apoyo-institucional-aumentar-fabricacion-tecnologia-sanitaria-espana.html). Access the original report: https://fenin.es/wp-content/uploads/2026/02/FENIN-Informe_Estudio-Fabricantes-TS-Espana-2025.pdf
    • Rovi increases R&D investment by 47% in 2025 (https://elglobalfarma.com/industria/rovi-incremento-inversion-id-2025/)
    • Almirall quadruples profits thanks to the surge in biological drugs (https://www.expansion.com/empresas/2026/02/23/699bf97e468aeb73618b459b.html)

7 days in healthcare (February 16th-22nd, 2026)

 

 

Summary

The week’s most impactful health news stories were:

  • Biomedicine: The Human Exposome Project will map how environmental factors influence our health.
  • Global Health: Leaving the WHO does not serve the best global or American interests.
  • International Health Policy: The days of Robert F. Kennedy, Jr.’s “wild” hegemony in health may be coming to an end.
  • National Health Policy: The doctors’ strike corners Minister García and puts thousands of appointments at risk.
  • Companies: BioNTech creates an mRNA vaccine to treat the most dangerous form of breast cancer.

Biomedicine

  • The Human Exposome Project will map how environmental factors influence our health. Several studies suggest that the cause of diseases is 20% genetic and 80% related to environmental factors.
  • Can shingles vaccines slow aging? The evidence is surprisingly strong. New data suggests it reduces the risk of dementia by 20%.
  • Cats offer clues for better cancer treatments. Similarities between tumors in cats and humans provide certain insights into treating diseases.

Global Health

  • Leaving the WHO does not contribute to the best global or American interests. The US seems to trust bilateral agreements more than global ones. Along these lines, it published the Global Health Strategy, which includes agreements with 15 countries, surprisingly without mentioning vaccines. Agreements with another 50 countries are planned. It also calls for a focus on certain infectious diseases—such as HIV/AIDS, malaria, tuberculosis, and polio—but not on maternal and child health, reproductive health, certain tropical diseases, non-communicable diseases, and other important health conditions.
  • The problems in the Cuban health system are deepening. The Cuban Minister of Health, José Ángel Portal Miranda, has acknowledged the poor situation. He has blamed the crisis on the American embargo, in line with the official position.
  • Health on the Front Lines: Four Years After the Start of the War in Ukraine. Russia’s full-scale invasion of Ukraine has been a catastrophe on all levels, including health. In four years, there have been more than 47,000 Ukrainian civilian casualties, 5-6 million people have emigrated, and 3-8 million have been internally displaced, disrupting their healthcare. The deliberate attack on healthcare facilities has been a substantial part of the Russian strategy.

International Health Policy

  • Robert F. Kennedy, Jr.’s days of “wild” hegemony in health may be ending. After letting him act freely until now, it seems the White House is beginning to worry about some of his initiatives.
  • Primary Care Deserts: Data Shows a Shortage of Primary Care Physicians in the UK. Four-fifths of integrated councils in England need to at least double their number of primary care physicians to reach staffing standards considered adequate, according to the British Medical Journal.
  • The British pharmacy sector sees Morrison’s sales as another warning sign for the NHS. The British giant is divesting itself of dozens of its community pharmacies to reduce costs; this situation highlights “the real economic danger facing pharmaceutical companies,” according to Community Pharmacy England.
  • The fragility of the healthcare system in Venezuela. Healthcare spending was 1.7% of GDP in 2018, well below the Latin American average of 4%. All indicators are very negative, even by regional standards.

National Health Policy (Spain)

  • The doctors’ strike corners Minister García and puts thousands of appointments at risk. The Platform of the Patients’ Organization (POP) estimates that cancellations could exceed 450,000. The Ministry maintains its intransigent position.
  • Mónica García fails to convince Junts in her first parliamentary blitz on the Public Management Law. Although the Minister of Health assures that the new law “does not harm the Catalan model,” the separatists respond that “neither you nor any minister has the right to say anything about how Catalonia is organized.” This law aims to make any public-private partnership mechanism virtually impossible, in addition to interfering in management aspects transferred to the autonomous communities. Although the chances of the law being approved are minimal, this does not diminish the extremely serious nature of the text’s content.
  • The Bioregion of Catalonia consolidates its leadership in the pharmaceutical industry. It concentrates 79 pharmaceutical production plants, 44% of the national total, and represents nearly 50% of the sector’s revenue, according to the Biocat 2025 Report, which analyzes the industrial, scientific, and regulatory weight of the Catalan ecosystem.

Companies

  • International
    • BioNTech creates an mRNA vaccine to treat the most aggressive form of breast cancer. The first clinical trial demonstrates that the vaccine creates a long-lasting immune response tailored to each patient’s tumor.
  • National
    • Ribera completes the acquisition of the Valencian group HCB Hospitales for €100 million. With a team of more than 650 professionals, it has two hospitals in Benidorm and Denia, three medical centers in Calpe, Moraira, and Albir, and two centers in Benidorm and Denia, as well as two diagnostic imaging centers in Alicante.

Biomedicine

  • Can shingles vaccines slow aging? The evidence is surprisingly strong. New data suggests it reduces the risk of dementia by 20% (https://www.economist.com/science-and-technology/2026/02/13/can-the-shingles-vaccine-slow-ageing)
  • The Human Exposome Project will map how environmental factors influence our health. Several studies suggest that the cause of diseases is 20% genetic and 80% related to environmental factors (https://www.economist.com/science-and-technology/2026/02/18/the-human-exposome-project-will-map-how-environmental-factors-shape-health)
  • Scientists say air pollution is linked to the risk of Alzheimer’s. Particles from fossil fuel combustion may damage the brain more than previously thought (https://www.ft.com/content/35c5904e-c1bc-452c-9f38-29b6b1b77066). Access the original article: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004912
  • Cats hold clues to better cancer treatments. Similarities between tumors in cats and humans offer some clues for treating diseases (https://www.ft.com/content/807ac68a-d96a-4da0-bdfc-5970c3c5a836)
  • Psychedelics found in Amazonian ayahuasca hold promise for treating depression. Single doses were able to eliminate the symptoms (https://www.ft.com/content/492f3a15-6c5d-4e26-8e1e-a24902d0bed3)
  • Tetris-based therapy shows promise in post-traumatic stress (https://www.ft.com/content/e185a5ed-833e-416d-9a10-e0178754dde0)
  • EDEN: The AI ​​system that learns from a million species to design new treatments. The model allows for the precise and complex modification of cells and molecules to cure diseases (https://elpais.com/ciencia/2026-02-18/eden-el-sistema-de-ia-que-aprende-de-un-millon-de-especies-para-disenar-nuevos-tratamientos.html)
  • Revolution in the treatment of multiple sclerosis: AI discovers new subtypes of this disease. British researchers have combined imaging tests and blood markers to describe two distinct patterns.
  • (https://www.elespanol.com/ciencia/salud/20260218/revolucion-tratamiento-esclerosis-multiple-ia-descubre-nuevos-subtipos-enfermedad/1003744132864_0.html)
  • Photonic technology to diagnose Alzheimer’s in Spain through the eyes. These diagnoses can be made quickly by observing the lens and retina using two different techniques (https://www.elespanol.com/ciencia/salud/20260217/tecnologia-fotonica-diagnosticar-alzheimer-espana-traves-ojos-puede-detectar-anos/1003744132793_0.html)

Global Health

  • Problems in the Cuban health system are deepening. Cuban Health Minister José Ángel Portal Miranda has acknowledged the dire situation. He has blamed the crisis on the American embargo, in line with the official position (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00356-9/fulltext)
  • Health on the front lines: four years after the start of the war in Ukraine. Russia’s full-scale invasion of Ukraine has been a catastrophe on all levels, including health. In four years, there have been more than 47,000 Ukrainian civilian casualties, 5-6 million people have emigrated, and 3-8 million have been internally displaced, disrupting their access to healthcare. The deliberate attack on healthcare facilities has been a substantial part of the Russian strategy (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00355-7/fulltext).
  • Leaving the WHO does not serve the best global or American interests. The US seems to rely more on bilateral agreements than on global ones. Along these lines, it published the Global Health Strategy, which includes agreements with 15 countries, surprisingly without mentioning vaccines. Agreements with another 50 countries are planned. It also calls for a focus on certain infectious diseases—such as HIV/AIDS, malaria, tuberculosis, and polio—but not on maternal and child health, reproductive health, certain tropical diseases, non-communicable diseases, and other major health conditions (https://www.science.org/doi/10.1126/science.aeg1937). Access the Global Health Strategy, September 2025: https://www.state.gov/wp-content/uploads/2025/09/America-First-Global-Health-Strategy-Report.pdf

International Health Policy

  • USA
    • Trump’s rejection of the fight against climate change is “a rejection of the laws of physics.” Scientists have condemned this initiative, labeling it a rejection of scientific logic (https://www.bmj.com/content/392/bmj.s324)
    • The FDA’s change of course on Moderna’s flu vaccine after pressure from the White House. This follows an interview between the FDA Commissioner and President Trump, who expressed his displeasure with the measure, according to Politico (https://www.politico.com/news/2026/02/18/fda-reverses-course-on-moderna-flu-shot-bid-00785799)
    • The days of Robert F. Kennedy, Jr.’s “wild” hegemony in health may be coming to an end. After letting him act freely until now, it seems the White House is starting to worry about some of his initiatives (https://www.politico.com/news/2026/02/21/rfk-midterms-maha-pesticides-vaccines-food-00792018)
    • Should over-the-counter medications be advertised to the public? Controversy begins over direct drug advertising, amid an offensive by certain brands regarding aging (https://www.nytimes.com/2026/02/16/health/drug-advertisements-consumers.html)
    • Measles makes a strong comeback in the United States, raising alarms. A total of 24 states are now affected by this disease, including Florida, Arizona, Washington, and South Carolina (https://www.vozpopuli.com/sanitatem/el-sarampion-vuelve-con-fuerza-a-estados-unidos.html)
  • China
    • Pharmaceutical consumption has grown more in China than in the USA in the last five years. A new report from IQVIA indicates that by the end of the decade, drug consumption will approach four trillion defined daily doses (DDDs). Growth is pronounced in China and modest in the United States. (https://diariofarma.com/2026/02/18/el-consumo-farmaceutico-crecio-mas-en-china-que-en-eeuu-en-los-ultimos-5-anos)
  • United Kingdom
    • Deserts in Primary Care: Data shows a shortage of primary care physicians in the United Kingdom. Four-fifths of integrated councils in England need to at least double their number of primary care physicians to reach staffing standards considered adequate, according to the British Medical Journal (https://www.bmj.com/content/392/bmj.s301)
    • English pharmacies see Morrison’s sales as another warning sign for the NHS. The British giant is divesting itself of dozens of its community pharmacies to reduce costs; this situation highlights “the real economic danger facing pharmaceutical companies,” according to Community Pharmacy England (https://diariofarma.com/2026/02/16/la-farmacia-inglesa-ve-en-la-venta-de-farmacias-morrison-otra-senal-de-alerta-grave-para-el-nhs)
  • France
    • The end-of-life debate returns to the National Assembly. The two texts on palliative care and assisted dying are being debated in the Assembly (https://www.lemonde.fr/politique/article/2026/02/16/fin-de-vie-le-debat-revient-a-l-assemblee-nationale-en-deuxieme-lecture_6666940_823448.html)
    • AIDS, malaria, tuberculosis: France reduces its contribution to the Global Fund by almost 60%. This decrease in aid is disappointing for the association, as these three diseases cause 2.5 million deaths worldwide each year (https://www.lemonde.fr/planete/article/2026/02/20/sida-paludisme-tuberculose-la-france-abaisse-de-pres-de-60-sa-contribution-au-fonds-mondial_6667596_3244.html)
    • The national health data platform is a strategic asset for France. This country possesses one of the world’s richest health data assets, but struggles to mobilize it for research, public health, and innovation, prior to the creation of the Health Data Hub in 2019 (https://www.lemonde.fr/idees/article/2026/02/16/la-plateforme-nationale-des-donnees-de-sante-est-un-actif-strategique-pour-la-france_6666976_3232.html)
  • Venezuela
    • The fragility of the health system in Venezuela. Health spending was 1.7% of GDP in 2018, well below the Latin American average of 4%. All indicators are very negative, even by regional standards (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00203-5/fulltext)
  • India
    • India’s pollution is an economic roadblock. Government inaction is a problem for its own development goals (https://www.economist.com/asia/2026/02/15/indias-pollution-is-becoming-an-economic-roadblock)

National Health Policy

  • Central Government Initiatives
    • The government postpones the selection of the headquarters for the State Public Health Agency until August. The government indicates this is due to the number of applications submitted and the construction work that would be required. This is not credible; rather, the reason is the delicate political situation with many elections, and that it is better to proceed in August (https://www.elespanol.com/invertia/observatorios/sanidad/20260217/gobierno-retrasa-agosto-eleccion-sede-agencia-salud-publica-obras-requieren-aspirantes/1003744133939_0.html)
    • The Public Health Agency will operate immediately, even without a headquarters. While the agency could operate from within the Ministry of Health (https://www.redaccionmedica.com/secciones/sanidad-hoy/la-agencia-de-salud-publica-operara-de-forma-inmediata-incluso-sin-sede-7235)
  • Regional Administrations
    • Basque Health Cluster and GSK seal a strategic alliance to boost healthcare innovation in Spain. The biopharmaceutical company joins as a Business Partner of the Basque cluster with the aim of strengthening open collaboration and accelerating the transformation of the healthcare ecosystem (https://www.consalud.es/salud35/nacional/basque-health-cluster-y-gsk-sellan-una-alianza-estrategica-para-impulsar-la-innovacion-sanitaria-en-euskadi.html)
    • Galicia secures its leadership in oncology: 23 million invested in CAR-T and the milestone of proton therapy. The Minister of Health, Antonio Gómez Caamaño, announces that the region will be the first to implement public proton therapy and will create a pioneering population-based genomic map (https://www.consalud.es/autonomias/galicia/galicia-blinda-liderazgo-oncologico-car-t-protonterapia-farmacos-propios.html)
    • The Bioregion of Catalonia consolidates its leadership in the pharmaceutical industry. It concentrates 79 pharmaceutical production plants, 44% of the national total, and represents nearly 50% of the sector’s revenue, according to the Biocat 2025 Report, which analyzes the industrial, scientific, and regulatory weight of the Catalan ecosystem (https://diariofarma.com/2026/02/19/la-bioregion-de-cataluna-consolida-su-liderazgo-en-la-industria-farmaceutica-en-espana)
    • Collaborative dispensing avoids 78,000 trips annually in Andalusia. The model for delivering hospital medication through community pharmacies increases the efficiency of the system and improves health outcomes (https://diariofarma.com/2026/02/18/la-dispensacion-colaborativa-evita-78-000-desplazamientos-anuales-en-andalucia)
    • The Galician government (Xunta) declares 29 special pharmaceutical zones to facilitate the viability of rural pharmacies. A total of 18 of the pharmacies are located in the province of Ourense and 11 in Lugo (https://diariofarma.com/2026/02/18/la-xunta-declara-las-29-zonas-farmaceuticas-especiales-para-facilitar-la-viabilidad-de-boticas-rurales)
  • Problems with the Framework Statute
    • The doctors’ strike corners Minister García and puts thousands of appointments at risk. The Platform of the Patient Organization (POP) estimates that cancellations could exceed 450,000 (https://www.elmundo.es/ciencia-y-salud/salud/2026/02/17/69934820fc6c8381138b45b2.html)
    • Doctors are making progress with the PP, Vox, and ERC to block the Framework Statute while their strike paralyzes healthcare. The group has secured a meeting with these three parliamentary groups with the aim of halting the legislation in Parliament (https://www.elespanol.com/invertia/observatorios/sanidad/20260219/medicos-avanzan-pp-vox-erc-frenar-estatuto-marco-huelga-paraliza-sanidad/1003744135944_0.html)
  • Measles
    • The WHO has issued a warning to Spain regarding its handling of the measles outbreak. Our country, along with five other European nations, has lost its status as a measles-free country. The recent outbreak in Alicante and the circulation of cases detected in Madrid this week do not suggest that the situation will reverse in the short term (https://www.elmundo.es/ciencia-y-salud/salud/2026/02/22/69975206e9cf4a6a0a8b456e.html)
  • Public Management Law
    • Mónica García fails to convince Junts in her first parliamentary debate on the Public Management Law. Although the Minister of Health assures that the new law “does not harm the Catalan model,” the separatists respond that “neither you nor any minister has any say in how Catalonia is organized” (https://diariofarma.com/2026/02/18/monica-garcia-no-convence-a-junts-en-el-primer-lance-parlamentario-sobre-la-ley-de-gestion-publica)

Companies

  • International
    • BioNTech creates an RNA vaccine to treat the most aggressive form of breast cancer. The first clinical trial demonstrates that the vaccine creates a long-lasting immune response tailored to each patient’s tumor (https://www.lavanguardia.com/ciencia/20260218/11468768/biontech-crea-vacuna-arn-tratar-cancer-mama-peor-pronostico.html)
    • Smartwatches still don’t accurately measure blood pressure. Current evidence suggests caution. A recent article analyzed whether these devices can truly replace clinically validated blood pressure monitors. The conclusion is clear: not yet (https://www.abc.es/salud/enfermedades/relojes-inteligentes-miden-bien-tension-arterial-20260218163713-nt.html)
    • Vaccines could enter a downward financial spiral. The reluctance of citizens and the US government is ultimately affecting corporate investment (https://cincodias.elpais.com/opinion/2026-02-20/las-vacunas-pueden-entrar-en-una-espiral-financiera-descendente.html)
  • National
    • Cofares breaks its sales record again with a 7.4% increase, reaching €4.58 billion. The pharmaceutical cooperative once again leads the wholesale market, with a 30% share (https://www.elespanol.com/invertia/observatorios/sanidad/20260218/cofares-vuelve-batir-record-facturacion-ventas-toca-millones-euros/1003744135496_0.html)
    • Lilly chooses Spain to manufacture its obesity pills. Alcobendas will host the final phase of orforglipron production. Thanks to an investment of over €300 million initiated in 2023 (https://es.linkedin.com/posts/el-mundo_lilly-apuesta-por-espa%C3%B1a-para-fabricar-las-activity-7429101551958437888-s7vU)
    • Ribera closes the purchase of the Valencian group HCB Hospitales for €100 million. With a team of over 650 professionals, it has two hospitals in Benidorm and Denia, three medical centers in Calpe, Moraira and Albir, and two centers in Benidorm and Denia, and two diagnostic imaging centers in Alicante. (https://www.elespanol.com/invertia/observatorios/sanidad/20260218/ribera-cierra-compra-grupo-valenciano-hcb-hospitales-millones/1003744135296_0.html)
    • ISDIN’s revenue is €648 million and its profit is 14% lower (https://www.expansion.com/catalunya/2026/02/18/69961283468aeb85408b45a2.html)

 

 

7 days in healthcare (February 8th-15th, 2026)

 

Summary

The most impactful health news of the week included:

  • Biomedicine: Obesity is linked to a 70% higher risk of serious infections.
  • Global Health: African countries must take control of their health policies.
  • International Health Policy: Trump revokes the greenhouse gas emissions assessment and intensifies the climate offensive.
  • National Health Policy: The government approves a bill intended to curb public management of healthcare. A complete absurdity and a compendium of sectarianism.
  • Business: Corporate health insurance becomes 10% more expensive, straining company budgets.

Biomedicine

  • Obesity is linked to a 70% higher risk of serious infections, including influenza and pneumonia.
  • The end of animals in medical experimentation? Both the US and UK governments are calling for an end to the use of animals in experimentation. But we must ask ourselves whether this approach is realistic and will not hinder research progress. The approach is based on New Approach Methodologies (NAMs). But until researchers find a model that allows them to model the entire human body, it will be difficult to do without animal experimentation.

Global Health

  • African countries must take control of their health policies. Massive aid cuts are having a devastating short-term effect, but they can help build more resilient systems in the long term.
  • Peru has had to recall thousands of cancer drugs due to contamination, interrupting cancer treatments. The Andean country has imported at least 118,000 vials of chemotherapy drugs that have ended up being discarded after failing quality tests since 2019, according to an investigation. One in four cancer patients has their treatment delayed due to drug shortages.

International Health Policy

  • Trump revokes the greenhouse gas emissions assessment and deepens the climate offensive. The revocation of the hazard assessment approved this Thursday by US President Donald Trump, issued in 2009 establishing that six greenhouse gases are harmful, is the latest in a series of measures by the Republican that run counter to efforts to curb climate change.
  • An important article in The Lancet by a group of prestigious academics analyzes the aspirations and implementation of the 10-year Health Plan for NHS England. The plan, published in July 2025, contains a series of policies, ambitions, and objectives. A chapter on implementation is expected.

National Health Policy (Spain)

  • The new law with which the government wants to curb private management of public healthcare, approved last Tuesday by the Council of Ministers, aims to limit forms of private participation in the public service. The text explicitly prohibits models of construction concessions with subsequent management of the hospital. The draft bill has been made public, giving a deadline of March 4th for submitting contributions to the Ministry. The text is a complete anti-European absurdity, with a ridiculous “scientific” approach in the preamble, a compendium of sectarianism, and harmful to the public healthcare sector. Its only redeeming quality is that it will never be approved, as that is not the intention; rather, it is to generate propaganda by publishing draft bills for which the government lacks a majority and, incidentally, to wage a political battle within “Más Madrid.”
  • Thousands of people demonstrated in Madrid against Ayuso’s healthcare policy. The demonstrators, called by unions and neighborhood associations on February 9th, demanded that the regional government halt the privatization of services, chanting “Either you have the checkbook or you’re going to the other side.”
  • The Community of Madrid has forgiven 71 million euros to private companies after they assumed responsibility for treating its patients. An internal document from the Ayuso government confirms that the public healthcare system loses millions every year by not billing private hospitals for many of the treatments it provides for its patients.
  • Castilla-La Mancha launches the H3.0 health plan with an emphasis on data management. It is a new healthcare model committed to integrating AI, robotics, data analytics, and precision and genomic medicine.
  • Some 5,000 doctors in Madrid are demanding the resignation of Mónica García and a specific Framework Statute for their profession. The demonstration on February 14th is a prelude to the five-day strike planned for next week, the first of five strikes scheduled until July. Whatever it may be called, doctors, whose doctor-patient relationship is the core of any healthcare system, need a distinct dialogue. Experience over the years has shown that this dialogue is lost amidst a multifaceted union representation that neither understands nor wants to understand doctors’ positions. The Ministry of Health is responsible for fueling this conflict with its intransigent stance.
  • The government has signed an agreement establishing a 21% profit margin for pharmacies (6% for distribution), to be reviewed every two years. Royal Decree 90/2026 on the financing and pricing of healthcare products introduces significant changes to their funding. The final text sets a 21% margin for pharmacies (6% for distribution) and strengthens economic control. It also establishes a review schedule by group for products already on the market.

Companies

  • International
    • Novo Nordisk intensifies its battle against Lilly by launching Wegovy in vials. Novo Nordisk will begin marketing Wegovy, its flagship drug, in vials, abandoning the exclusivity of the plastic injection pens it has used until now. This will represent a key strategic shift in its fight for dominance in the weight-loss drug market.
  • National
    • Corporate health insurance becomes 10% more expensive, putting pressure on company budgets. Corporate spending on health will remain around 9% in 2026.

Biomedicine

  • The end of animals in medical experimentation? Both the US and UK governments are calling for an end to the use of animals in experimentation. But we must ask ourselves whether this approach is realistic and will not hinder the progress of research. The approach is based on New Approach Methodologies (NAMs). But until researchers find a model that allows them to model the entire human body, it will be difficult to do without animal experimentation (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00298-9/abstract).
  • Obesity is linked to a 70% higher risk of serious infections, including influenza and pneumonia (https://www.ft.com/content/b6f8a203-c2e5-4e34-bec8-3e0111b37e16). Access the original Lancet study: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02474-2/fulltext
  • 2-3 cups of coffee a day are linked to a lower risk of Alzheimer’s, but not if it’s decaffeinated. This conclusion was reached after following 132,000 people for 40 years (https://www.nytimes.com/2026/02/09/health/coffee-tea-dementia-risk.html). Access the original JAMA article: https://jamanetwork.com/journals/jama/article-abstract/2844764?guestAcces%5b…%5dferral&utm_campaign=ftm_links&utm_content=tfl&utm_term=020926
  • The shortcomings of the ChapGPT test for medical diagnosis (https://www.lemonde.fr/pixels/article/2026/02/09/les-failles-de-chatgpt-pour-l-autodiagnostic-medical-revelees-par-une-etude_6666026_4408996.html). Access the original article: https://cdn.openai.com/pdf/2cb29276-68cd-4ec6-a5f4-c01c5e7a36e9/OpenAI-AI-as-a-Healthcare-Ally-Jan-2026.pdf

Global Health

  • African countries must take control of their health policies. Massive aid cuts are having a devastating short-term effect, but can help build more resilient systems in the long run (https://www.nature.com/articles/d41586-026-00381-7)
  • Peru has had to recall thousands of cancer drugs due to contamination, disrupting cancer treatments. The Andean country has imported at least 118,000 vials of chemotherapy drugs that have ended up being discarded after failing quality tests since 2019, according to an investigation. One in four cancer patients experiences delays in treatment due to drug shortages (https://elpais.com/planeta-futuro/2026-02-12/peru-retira-miles-de-medicamentos-importados-contra-el-cancer-por-estar-contaminados-interrumpiendo-tratamientos-vitales.html)

International Health Policy

  • USA
    • Trump revokes greenhouse gas hazard assessment and deepens climate offensive. The revocation of the hazard assessment approved this Thursday by US President Donald Trump, issued in 2009 establishing that six greenhouse gases are harmful, is the latest in a series of measures by the Republican that run counter to efforts to curb climate change. (https://www.elindependiente.com/economia/2026/02/13/trump-revoca-el-dictamen-de-peligrosidad-de-los-gases-de-efecto-invernadero-y-profundiza-su-ofensiva-climatica/)
    • The Trump Administration withdraws $600 million in healthcare funding from four Democratic states: California, Colorado, Illinois, and Minnesota (https://www.nytimes.com/2026/02/09/health/trump-public-health-cuts-california.html)
  • China
    • Drug use in China will double by 2030, while it stabilizes in the USA, Europe, and Japan. A new report from IQVIA highlights that the drugs that will contribute most to increased spending will be those for oncology, immunology, diabetes, and obesity (https://elglobalfarma.com/industria/medicamentos-china-duplicara-2030-europa-eeuu-japon-estabiliza/)
  • United Kingdom
    • An important article in The Lancet by a group of prestigious academics analyzes the aspirations and implementation of the 10-year Health Plan for NHS England. The plan, published in July 2025, contains a series of policies, ambitions, and objectives. A chapter on implementation is expected (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00035-8/abstract)
    • Millions of women in the UK have access to only one IVF cycle through the NHS. Health authorities continue to cut availability, despite official policies (https://www.ft.com/content/cd560417-8e6b-40fc-b23c-e305fe9fb753)
  • France
    • French people exposed to worrying levels of cadmium, lead, and aluminum through food, warns the French Agency for Health Safety (https://www.lemonde.fr/sante/article/2026/02/12/cadmium-plomb-aluminium-les-francais-exposes-a-des-niveaux-preoccupants-via-l-alimentation-alertent-les-autorites-de-sante_6666416_1651302.html)
  • India
    • A patient-centered health system for India. The Indian health system is undergoing a shift towards universal coverage, a crucial component for raising the country’s development status by 2047. The Lancet Commission has made many proposals (https://www.thelancet.com/commissions-do/india-citizen-health)

National Health Policy

  • Central Government Initiatives
    • The new law with which the government wants to curb private management in public healthcare, approved last Tuesday by the Council of Ministers, aims to limit forms of private participation in the public service. The text explicitly prohibits models of construction concessions with subsequent hospital management. The draft text has been made public, giving a deadline of March 4th for submitting contributions to the Ministry. The general impression is that the text will not be approved and that it is part of a policy of approving propaganda texts that then never come into effect because they are not passed (https://www.elconfidencial.com/salud/2026-02-10/nueva-ley-frenar-la-gestion-privada-en-la-sanidad-publica_4300485/)
    • Brussels questions the government’s new anti-smoking law. The European Commission and the CNMC warn the Ministry of Health of legal risks, lack of proportionality, and potential distortions of the internal market (https://www.larazon.es/sociedad/bruselas-cuestiona-nueva-ley-antitabaco-monica-garcia_20260210698a83f79243cc133c3e799f.html)
    • Up to seven health initiatives hope to pass Congress, including the law to limit public-private partnerships, the tobacco law, the framework statute, the medicines law, and the alcohol law (https://www.consalud.es/politica/hasta-siete-iniciativas-sanitarias-aspiran-a-superar-el-complejo-liston-del-congreso.html)
  • Regional governments
    • A report links the precarious state of Emergency Departments in Catalonia with hospital mortality. The Catalan Audit Office and unions denounce the long waiting times and lack of resources in the region’s emergency rooms (https://www.vozpopuli.com/espana/cataluna/un-informe-vincula-la-precariedad-en-las-urgencias-de-cataluna-con-la-mortalidad-hospitalaria.html)
    • The map of the Catalan healthcare system is presented, prioritizing proximity. The new model, although reducing the number of management areas from 43 to 30, promises to “adapt to the specific characteristics of each territory.” (https://elpais.com/espana/catalunya/2026-02-10/salud-presenta-el-mapa-del-sistema-sanitario-catalan-con-la-creacion-de-30-areas-integradas.html)
    • Thousands of people demonstrate in Madrid against Ayuso’s healthcare policy. The protesters, called together by unions and neighborhood associations, are demanding that the regional government halt the privatization of services, chanting “either you have a checkbook or you’re going to the other side” (https://elpais.com/espana/madrid/2026-02-08/miles-de-personas-se-manifiestan-en-madrid-contra-la-politica-sanitaria-de-ayuso.html)
    • The Community of Madrid has forgiven 71 million euros to private companies after they assumed responsibility for and treated its patients. An internal document from the Ayuso government confirms that the public health system loses millions every year by not billing private hospitals for many of the treatments it provides for its patients. (https://www.eldiario.es/sociedad/comunidad-madrid-perdonado-71-millones-quiron-ribera-salud-asumir-tratar-pacientes_1_12899576.html)
    • Castilla-La Mancha launches the H3.0 health plan with an emphasis on data management. It is a new healthcare model committed to integrating AI, robotics, data analytics, and precision and genomic medicine. (https://www.diariomedico.com/medicina/politica/castilla-mancha-pone-marcha-plan-salud-h30-foco-gestion-datos.html)
    • Cantabria signs improvements with doctors. Its objective is to attract and retain medical professionals, including resident physicians, in the regional health service. (https://www.diariomedico.com/medicina/politica/cantabria-buruaga-firma-medicos-mejoras-supeditadas-presupuestos.html)
  • Problems with the Framework Statute
    • Some 5,000 doctors in Madrid are demanding the resignation of Mónica García and their own Framework Statute. The demonstration is a prelude to the five-day strike planned for next week, the first of five planned until July (https://elpais.com/sociedad/2026-02-14/unos-5000-medicos-piden-en-madrid-la-dimision-de-monica-garcia-y-un-estatuto-marco-propio.html)
  • Patient Organizations Law
    • Patient associations disagree on the new law: POP is against it, while the Foro is in favor. The Platform of Patient Organizations (POP) is calling for the correction of Article 2 of the regulations, as it leaves the concept of “patient association” too broad (https://www.elespanol.com/invertia/observatorios/sanidad/20260211/desacuerdo-organizaciones-pacientes-nueva-ley-no-soluciona-problema-viene-corregir/1003744125483_0.html)
  • Pharmacy
    • The government signs a 21% margin for pharmacies (6% for distributors), to be reviewed every two years. Royal Decree 90/2026 on the financing and pricing of healthcare products introduces significant changes to their financing. The final text sets a 21% margin for pharmacies (6% for distributors) and strengthens economic control. It also establishes a review schedule by product group for products already on the market. (https://diariofarma.com/2026/02/12/el-gobierno-fija-en-el-21-el-margen-de-los-ppss-en-farmacia-se-revisara-cada-dos-anos)

Companies

  • International
    • Novo Nordisk intensifies its battle against Lilly by launching Wegovy in vials. Novo Nordisk will begin marketing Wegovy, its flagship drug, in vials, abandoning the exclusivity of the plastic injection pens it has used until now. This will represent a key strategic shift in its fight for dominance in the weight-loss drug market. (https://www.expansion.com/empresas/2026/02/12/698dc8eee5fdea0b138b4727.html)
    • AstraZeneca expects to earn €8.597 billion in 2025, a 54.3% increase, and raises its annual dividend (https://www.elespanol.com/invertia/observatorios/sanidad/20260210/astrazeneca-gana-millones-euros-eleva-dividendo-anual/1003744124842_0.html)
  • National
    • Corporate health insurance becomes 10% more expensive, putting pressure on company budgets. Corporate spending on healthcare will remain around 9% in 2026. Prevention and claims management are key to maintaining profits (https://cincodias.elpais.com/extras/ciencia-salud/2026-02-14/el-seguro-medico-corporativo-se-encarece-un-10-y-tensiona-los-presupuestos-de-las-empresas.html)
    • Roche Diagnostics is considering layoffs of up to 50 people in Sant Cugat. The Swiss pharmaceutical company Roche has filed for workforce reductions at Roche Diagnostics, its subsidiary specializing in diagnostics, whose Spanish headquarters are located in Sant Cugat del Vallés (Barcelona) (https://www.expansion.com/catalunya/2026/02/13/698f7e45e5fdea4e028b45c4.html)
    • Abbott is considering expanding its plant in Granada due to increased demand in nutrition. The multinational medical technology company exports from its factory in Andalusia to 65 countries. (https://cincodias.elpais.com/extras/ciencia-salud/2026-02-13/abbott-estudia-la-ampliacion-de-su-planta-de-granada-por-la-mayor-demanda-en-nutricion.html)

 

 

7 days in healthcare (February 2nd-8th, 2026)

 

Summary

The most impactful health news of the week included:

  • Biomedicine: More than a third of cancers originate from preventable risk factors.
  • Global Health: Biblical diseases may resurface in Africa.
  • International Health Policy: TrumpRx, the online drug store, launches.
  • National Health Policy: Following the AIREF report, the Social Security system convenes social partners to discuss the lack of control over sick leave.
  • Companies: Asisa will increase its doctors’ compensation by 7.3% by 2026.

Biomedicine

  • More than a third of cancers originate from preventable risk factors. Tobacco, infections, and alcohol are the main causes. The study published in Nature Medicine states that of the 20 million cancers diagnosed in 2022, 38% were caused by preventable factors. It is the most comprehensive study conducted to date on preventable causes of cancer and confirms tobacco as the greatest risk factor.
  • Electronic cigarettes: a comprehensive study outlining the risks. After reviewing 3,000 articles, the French Agency for Health Safety (ANSES) states that vaping poses short- and long-term health risks, while acknowledging its value in smoking cessation.

Global Health

  • Biblical diseases may resurface in Africa. Parasites and infections that cause blindness and other disabilities had been nearly eradicated in some countries, but the distribution of medications to treat and prevent them has been halted in many places by 2025, following the cessation of US aid (USAID).
  • Venezuela: health after the political earthquake. More than 20 million Venezuelans live in abject poverty, without access to medicines. The current crisis is chronic and a result of the corruption and mismanagement of the Chávez and Maduro governments.

International Health Policy

  • TrumpRx, the online drug store, launches. According to the New York Times, researchers say the public may end up paying too much if they use this store. The website will not sell medications, but will only indicate where they can be purchased and at what price. It is backed by agreements with some pharmaceutical companies. The website will offer information on 43 medications, from insulin to obesity therapies. It is unlikely that Americans will save money with this method; many medications are covered by insurance, and cheaper generic versions of many others are available. Around 85% of Americans have prescription drug insurance coverage.
  • The FDA launches PreCheck incentives to revitalize domestic pharmaceutical manufacturing. “After 35 years of globalists moving pharmaceutical manufacturing overseas, the FDA is taking bold steps to bring it back,” says FDA Commissioner Marty Makary.
  • The NHS agreement with the United States will cost the United Kingdom £1 billion over the next three years. The Minister of Science says the NHS will obtain this money outside its regular budget.

National Health Policy (Spain)

  • Following the AIREF report, the Social Security system is calling a meeting with social partners regarding the lack of control over sick leave. The Secretary of State will meet on Monday with unions and employers’ associations after the Fiscal Authority’s report blames the Social Security system for failing to control sick leave.
  • This is how other statutes governing the medical profession in Europe work. In neighboring countries with different terminology, doctors have exclusive regulations and negotiating bodies. According to FEMS (European Federation of Salaried Doctors), only Croatia and Romania have the same structure as Spain.

Companies

  • International
    • Lilly’s Mounjaro takes over from Novo Nordisk as the top-selling obesity medication.
  • National News
    • Asisa will increase its doctors’ compensation by 7.3% by 2026. The insurer will apply the increase retroactively from January 1st, with increases that can exceed 16% depending on the specialty and level of service.
    • Spain will spend as much on health insurance as on car insurance in 2027. In 2025, health insurance premiums increased by 11.43%, to €13.443 billion, the highest growth among the main non-life insurance lines.

Biomedicine

  • More than a third of cancers originate from preventable risks. Tobacco, infections, and alcohol are the main causes. The study published in Nature Medicine says that of the 20 million cancers diagnosed in 2022, 38% originated from preventable causes. It is the largest study to date on preventable causes of cancer and confirms tobacco as the greatest risk factor (https://www.economist.com/science-and-technology/2026/02/04/more-than-a-third-of-cancers-arise-from-preventable-risks). Access the original article: https://www.nature.com/articles/s41591-026-04219-7
  • Cancers, immunotherapy, the revolutionary treatment that presents risks. Emerging in the early 2010s, this treatment produces toxicities in 10-50% of patients (https://www.lemonde.fr/sciences/article/2026/02/03/cancers-les-immunotherapies-des-traitements-revolutionnaires-qui-presentent-des-risques_6665255_1650684.html)
  • Electronic cigarettes: a comprehensive study outlining the risks. After reviewing 3,000 articles, the French Agency for Health Safety says that vaping poses short- and long-term health risks, while acknowledging its value in smoking cessation (https://www.lemonde.fr/planete/article/2026/02/04/cigarette-electronique-l-anses-rend-un-avis-prudent-sur-les-risques-sanitaires-du-vapotage_6665288_3244.html)
  • A brain implant allows a person blinded by optic nerve damage to regain their sight. Scientists at the Miguel Hernández University of Elche stimulated the visual cortex of a blind man until he was able to perceive light, movement, and even large letters (https://elpais.com/ciencia/2026-02-03/un-implante-en-el-cerebro-permite-recuperar-la-vision-a-un-hombre-ciego-por-una-lesion-en-el-nervio-optico.html)
  • CRISPR allows targeting tumors with amplified oncogenes and points to precision therapies. Preclinical results from a study by the CNIO and CIEMAT show that gene editing points to new precision therapies against resistant cancers (https://diariofarma.com/2026/02/05/crispr-permite-atacar-tumores-con-oncogenes-amplificados-y-apunta-a-terapias-de-precision)

Global Health

  • Venezuela: health after the political earthquake. More than 20 million Venezuelans live in abject poverty, without access to medicine. The current crisis is chronic and a result of the corruption and mismanagement of the Chávez and Maduro governments (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00249-7/fulltext)
  • Biblical diseases may resurface in Africa. Parasites and infections that cause blindness and other disabilities had been nearly eliminated in some countries, but the distribution of medicines to treat and prevent them has been halted in many places by 2025, following the end of US aid (USAID) (https://www.nytimes.com/2026/02/03/health/neglected-tropical-diseases-usaid-ntds-river-blindness.html)

International Health Policy

  • USA
    • TrumpRx, the online drug store, launches. According to the New York Times, researchers say the public may end up paying too much if they use this store. The website will not sell medications, but will only indicate where they can be purchased and at what price. It is backed by agreements with some pharmaceutical companies. The website will offer information on 43 medications, from insulin to obesity therapies. It is unlikely that Americans will save money with this method; many medications are covered by insurance, and cheaper generic versions of many others are available. Around 85% of Americans have drug insurance coverage (https://www.nytimes.com/2026/02/05/health/trumprx-online-drugstore-prices.html)
    • The FDA launches PreCheck incentives to boost domestic pharmaceutical manufacturing. “After 35 years of globalists moving pharmaceutical manufacturing abroad, the FDA is taking bold steps to bring it back,” says FDA Commissioner Marty Makary (https://diariofarma.com/2026/02/01/la-fda-lanza-los-incentivos-precheck-para-relanzar-la-fabricacion-farmaceutica-nacional-de-ee-uu)
    • Millions of Americans lose their health insurance as COVID-19 subsidies disappear. With insurance prices rising, around 4.8 million Americans could lose their coverage (https://www.thelancet.com/action/showPdf?pii=S0140-6736%2826%2900251-5)
    • In the USA, science skeptics are now in power. According to The Economist, the American government seems to want less clean energy and more preventable diseases (https://www.economist.com/science-and-technology/2026/02/04/in-america-science-sceptics-are-now-in-charge)
    • The right to die is spreading in the USA. States where a third of the population lives may soon allow assisted dying (https://www.economist.com/united-states/2026/02/02/the-right-to-die-is-spreading-in-america)
  • China
    • More and more foreigners are choosing to go to China for healthcare. The influx of tourists is creating problems for locals (https://www.economist.com/china/2026/02/05/why-more-foreigners-are-seeking-health-care-in-china)
  • United Kingdom
    • The NHS deal with the United States will cost the UK £1 billion over the next three years. The science minister says the NHS will raise this money outside its regular budget (https://www.ft.com/content/624bf05e-5a37-4b17-96ec-3f64c0a624fa)
    • A growing number of adults in the UK are turning away from alcohol, which is driving the trend. 24% of British adults say they don’t drink (https://www.bmj.com/content/392/bmj.s207)
    • Residents vote for six more months of labor demands with strikes (https://www.bmj.com/content/392/bmj.s218)
  • France
    • The right to assisted dying is again approved by MPs in committee. After being rejected in the Senate, it returns to the Congress for a second reading (https://www.lemonde.fr/societe/article/2026/02/05/le-droit-a-l-aide-a-mourir-est-a-nouveau-approuve-par-les-deputes-en-commission_6665440_3224.html)
    • Participatory health centers, deployed in 2021 in disadvantaged neighborhoods, at risk due to budget cuts (https://www.lemonde.fr/societe/article/2026/02/05/acces-aux-soins-inquietude-autour-des-26-centres-de-sante-participatifs-un-dispositif-medical-dans-des-quartiers-defavorises_6665528_3224.html)
  • Brazil
    • Brazil mistakenly discovers that 13,000 medical students about to graduate lack the basic knowledge required to practice. A third of university courses failed the first national assessment of medical education. The faculties with the worst scores are municipal or private (https://elpais.com/america/2026-02-02/brasil-descubre-con-alarma-que-13000-alumnos-a-punto-de-acabar-medicina-no-saben-lo-minimo-para-ejercer.html)
    • It appears that the possibility of implementing the Spanish MIR (Medical Residency) model is being analyzed. The debate over a mandatory exam to practice medicine in Brazil has reopened comparisons with the Spanish system of Specialized Health Training, where access to and professional accreditation as a specialist have been regulated by national exams for decades (https://www.consalud.es/formacion/brasil-hacia-el-modelo-mir-espanol-para-garantizar-la-calidad-medica.html)
  • WHO
    • The WHO code on international recruitment of doctors does not strengthen poor health systems. A study published in ‘JAMA Health Forum’ concludes that the regulation temporarily reduced emigration from countries with a shortage of doctors, but did not improve staffing levels (https://www.diariomedico.com/medicina/politica/codigo-oms-contratacion-internacional-medicos-refuerza-sistemas-sanitarios-pobres.html). Access the original JAMA article: https://doi.org/10.1001/jamahealthforum.2025.6718
    • The WHO’s list of priority pathogens: key to curbing antimicrobial resistance. A publication in Science Direct analyzes the list (https://www.consalud.es/pacientes/la-lista-de-patogenos-prioritarios-de-la-oms-clave-para-frenar-la-resistencia-a-los-antimicrobianos.html).

National Health Policy

  • Central Government Initiatives
    • The proposed patients’ rights law is progressing, with association support. The Spanish Patients’ Forum and the POP acknowledge the Ministry’s effort to provide a differentiated and cross-cutting perspective for these organizations (https://diariofarma.com/2026/02/04/la-propuesta-de-sanidad-para-la-ley-de-pacientes-avanza-con-el-apoyo-de-las-asociaciones)
  • Initiatives of the Autonomous Communities
    • The Government of Cantabria and FENIN advance a plan to turn the region into a healthcare innovation hub (https://www.consalud.es/autonomias/cantabria/el-gobierno-de-cantabria-y-fenin-avanzan-un-plan-para-convertir-la-region-en-hub-de-innovacion-sanitaria.html)
    • Strengthening staff or improving productivity: electoral proposals regarding waiting lists in Aragon. It seems the PP is focusing on attracting and retaining professionals, increasing the availability of operating rooms, and coordinating specialized services, while the PSOE is prioritizing increased funding and more staff (https://www.consalud.es/autonomias/aragon/reforzar-plantillas-o-incentivos-de-productividad-propuestas-electorales-ante-las-listas-de-espera-en-aragon.html)
    • Mental health and reducing waiting lists are among the objectives of the SERGAS management agreements (https://www.diariomedico.com/medicina/politica/consulta/salud-mental-reducir-listas-espera-objetivos-acuerdos-gestion-sergas.html)
  • Sick leave
    • Following the AIREF report, the Social Security system is convening with social partners to address the lack of control over sick leave. The Secretary of State will meet on Monday with unions and employers following the report from the Independent Authority for Fiscal Responsibility (AIReF) that blames the Social Security system for failing to control sick leave. (https://www.elconfidencial.com/economia/2026-02-06/seguridad-social-convoca-agentes-sociales-descontrol-bajas-medicas_4298747/) Access the AIReF spending review report: https://www.airef.es/wp-content/uploads/2026/02/SpendingReview-2022-2026-fase-2/SR2226F2_IT.pdf
  • MIR Exam
    • The 2026 exam breaks records for annulled questions (https://theobjective.com/sanidad/2026-02-07/examen-mir-record-preguntas-anuladas/)
  • Framework Statute
    • This is how the other statutes of the The medical profession in Europe. In neighboring countries with different terminology, doctors have their own exclusive rules and negotiation forums. According to the FEMS (European Federation of Medical Students), only Croatia and Romania are in the same situation as Spain. (https://www.diariomedico.com/medicina/profesion/asi-son-estatutos-profesion-medica-europa.html)
    • Murcia points to the government as responsible for the conflict over the Framework Statute (https://www.consalud.es/autonomias/murcia/murcia-senala-al-gobierno-como-responsable-del-conflicto-por-el-estatuto-marco.html)
    • Vox wants the parties in Congress to take a position on the Statute for doctors (https://www.elespanol.com/invertia/observatorios/sanidad/20260204/vox-quiere-partidos-congreso-posicionen-den-opinion-estatuto-marco-propio-medicos/1003744116090_0.html)
  • Cancer
    • The Spanish Association Against Cancer says that everything related to cancer is being deprioritized. According to the president of this association, Europe is deprioritizing cancer (https://www.elmundo.es/ciencia-y-salud/salud/2026/02/04/698210d6e4d4d8413b8b4584.html)

Companies

  • International
    • Lilly’s Mounjaro takes over from Novo Nordisk as the top-selling obesity drug (https://www.elespanol.com/invertia/observatorios/sanidad/20260205/mounjaro-lilly-coge-relevo-novo-nordisk-mayor-superventas-obesidad/1003744117073_0.html)
    • Pfizer will lose €1.3 billion in 2026 due to the expiration of several patents and competition from generics and biosimilars (https://www.elespanol.com/invertia/observatorios/sanidad/20260204/pfizer-perdera-millones-caducidad-varias-patentes-competencia-genericos-biosimilares/1003744115331_0.html)
  • National
    • Asisa Asisa will raise its doctors’ salaries by 7.3% by 2026. The insurer will apply the increase retroactively from January 1st, with increases that can exceed 16% depending on the specialty and level of service (https://www.consalud.es/salud35/nacional/asisa-eleva-un-73-la-retribucion-de-sus-medicos-para-2026.html)
    • Ribera Povisa consolidates its leading position in Galicia after handling more than 400,000 consultations in 2025 (https://www.consalud.es/industria/sanidad-privada/ribera-povisa-consolida-su-referencia-en-galicia-tras-atender-mas-de-400000-consultas-en-2025.html)
    • Spain will spend as much on health insurance as on car insurance in 2027. In 2025, health insurance premiums increased 11.43%, to 13,443 million euros, the largest growth among the main non-life branches (https://kiosco.eleconomista.es/e-paper/viewer.aspx?publication=Sanidad&date=05_02_2026&tpuid=690#page/6)

7 days in healthcare (January 26th-February 1st, 2026)

 

Summary

The week’s most impactful health news stories were:

  • Biomedicine: AlphaGenome, a Google AI, predicts the impact of DNA variations.
  • Global Health: The humanitarian situation in Yemen will worsen in 2026.
  • International Health Policy: Following donations, the Trump Administration rescinds the order requiring more staff in nursing homes.
  • National Health Policy: The Ministry of Health signs the Framework Statute agreement with unions, but without the support of doctors.
  • Business: According to Elon Musk, there will be no nursing homes in the future; he claims his robots will be able to protect and care for the elderly.

Biomedicine

  • AlphaGenome, a Google AI, predicts the impact of DNA variations. This tool could be used to obtain more information about genetic diseases, improve genetic testing, and contribute to the development of new treatments.
  • Genes control longevity, regardless of how healthy a lifestyle is. Each person’s life expectancy potential is written in their genes, according to a new study.
  • AI improves mammogram readings: it detects more tumors, especially the most aggressive ones, and reduces the number of missed ones. A Swedish clinical trial with more than 100,000 women shows that AI in mammogram screening detects more relevant cancers without increasing false positives.

Global Health

  • The humanitarian situation in Yemen will worsen in 2026. An 11-year-long civil war will contribute to the spread of infectious diseases, malnutrition, and maternal mortality.
  • How to eat well within Earth’s limits. The impact of new recommendations from RFK Jr., which call for increased protein, fruit, and vegetable consumption, is discussed.

International Health Policy

  • Following donations, the Trump Administration rescinds the order requiring more staff at nursing homes. According to the New York Times, executives from these companies met with Trump, made a significant donation, and the project was withdrawn.
  • China is changing the rules in biotech. For over 100 years, the USA was the undisputed leader in biomedical research and innovation. China’s major advances put the USA at risk of losing that position.
  • According to the British Prime Minister, the drop in vaccinations in the UK is a “national disgrace.” The vaccination strategy in England is failing.
  • How politics destroyed a model healthcare system in Colombia. For the last two decades, Colombia’s healthcare system was seen as an example for the rest of Latin America, both by the WHO and the World Bank. None of that changed President Petro’s mind, and he is trying to impose a radical change.

National Health Policy (Spain)

  • The Ministry of Health signs the agreement on the Framework Statute with the unions, but without the support of the doctors. Logically, in any healthcare system, doctors are not just another part. They are the key players most closely related to the quality of care. Their lack of agreement is not something that can be disregarded; rather, it invalidates any agreement. The doctors are prepared to continue defending their position through parliamentary channels.
  • A book by FUNCAS challenges the entrenched myths (or myths) about the Spanish public healthcare system. Whether we have the best healthcare system in the world, whether there is a shortage of doctors in Spain, or whether there is truly a shortage of 100,000 nurses, are among the topics analyzed. Among other things, it discusses whether we have the best or one of the best healthcare systems in the world. We do now have some health outcomes that can be correlated with the activity of the healthcare system. In fact, Spain ranked 9th among all countries in the world in the HAQ index (which measures clinically avoidable mortality) in 2022, with only eight countries ahead of it, all of them smaller (Switzerland, Sweden, Norway, Canada, the Netherlands, Australia, Iceland, and Ireland). Now, even if we were number one in health outcomes, that wouldn’t authorize us to say we have the best healthcare system in the world. It’s important to remember that the purpose of healthcare systems isn’t just to “save lives.” They have other valuable functions, difficult to reflect in rankings: reducing patient disability, alleviating pain, making illnesses more bearable, resolving uncertainty, and decreasing physical and emotional distress. These systems are justified by the fulfillment of their specific goals: to care, prevent, rehabilitate, and reassure.
  • Spain already has 40 CAR-T centers, reflecting the expansion of advanced therapies. The Ministry has published a report that takes stock of treatment with Advanced Therapies in 2025, with five new centers and 2,742 applications processed since 2019.

Companies

  • International
    • According to Elon Musk, there will be no nursing homes in the future; he claims his robots will be able to protect and care for the elderly. He proposes his humanoid robots as a solution to the shortage of caregivers and the high cost of elder care.
    • The historic trade agreement between the US and India will boost pharmaceutical trade. The pact will gradually eliminate Indian tariffs on European medicines and seeks to strengthen supply chains in a context of geopolitical tensions.
  • National
    • GSK, Sanofi, and MSD are the companies receiving the most funding from the $1.7 billion mega-contract for vaccines.

Biomedicine

  • Dr. William Foege, a key figure in the global eradication of smallpox, has died. He was director of the US Centers for Disease Control and Prevention (CDC) in the late 1970s and early 1980s (https://www.elmundo.es/ciencia-y-salud/salud/2026/01/26/697716f8fc6c8310558b4572.html)
  • AlphaGenome, a Google AI, predicts the impact of variations in DNA. This tool could be used to obtain more information about genetic diseases, improve genetic testing, and contribute to the development of new treatments (https://www.diariomedico.com/medicina/genetica/alphagenome-ia-google-predice-impacto-variaciones-adn.html). Original article in the journal Nature: https://www.nature.com/articles/s41586-025-10014-0
  • The surprisingly good results of just a little exercise. Exercise snacks and other forms of daily movement may help reduce the risk of death from heart disease (https://www.nature.com/articles/d41586-026-00237-0)
  • Scientists link 22 genes to common viral risks. Scientists have identified these genes, which explain how many people are at risk of life-threatening illnesses (https://www.ft.com/content/815dd3d9-f83b-448d-af52-ca6da6c9cd03)
  • Ultrasound is being used to treat treatment-resistant depression. Deep brain stimulation could improve severe depression (https://www.lemonde.fr/sciences/article/2026/01/28/les-ultrasons-a-l-assaut-des-depressions-resistantes_6664406_1650684.html)
  • Genes control longevity, regardless of how healthy a lifestyle is. Your lifespan potential is written in your genes, according to a new study (https://www.nytimes.com/2026/01/29/health/longevity-lifespan-age-genes.html). Access the original article in Science: https://www.science.org/doi/10.1126/science.adz1187
  • Mariano Barbacid cures pancreatic tumors in rats with a combination of three drugs. The Spanish researcher estimates that the first human trials will begin in three years and will require an investment of 30 million euros (https://www.abc.es/salud/enfermedades/mariano-barbacid-consigue-curar-tumores-pancreas-animales-20260127135426-nt.html)
  • AI improves mammogram readings: it detects more tumors, especially the most aggressive ones, and reduces those that went unnoticed. A Swedish clinical trial with more than 100,000 women shows that AI in mammographic screening detects more relevant cancers and reduces interval tumors by 12% without increasing false positives (https://www.elmundo.es/ciencia-y-salud/salud/2026/01/30/697b9345e4d4d8fb578b458d.html)

Global Health

  • The BMJ’s call: hospitals should be sanctuaries, not military targets (https://www.bmj.com/content/392/bmj.s115?nbd_source=adestra&nbd=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)
  • Infections are rampant in Sudan’s fields (https://www.bmj.com/content/392/bmj.s87?nbd_source=adestra&nbd=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)
  • The humanitarian situation in Yemen will worsen in 2026. A civil war The fact that this pandemic has already lasted 11 years will contribute to the proliferation of infectious diseases, malnutrition, and maternal mortality (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00196-0/fulltext)
  • How to eat well and within Earth’s limits. The impact of RFK Jr.’s new recommendations, which call for increased protein, fruit, and vegetable consumption, is being discussed (https://www.nature.com/articles/d41586-026-00236-1)
  • The number of people living in extreme heat by 2050 will double if temperatures rise by 2°C. Scientists believe that 41% of the population will experience these temperatures, with no part of the world immune (https://www.theguardian.com/environment/2026/jan/26/number-of-people-living-in-extreme-heat-to-double-by-2050-if-2c-rise-occurs-study-finds)

International Health Policy

  • USA
    • American medical groups will go to court to stop RFK Jr.’s vaccine changes. A coalition of doctors and public health advocacy groups will file a legal motion to halt the changes to the vaccination schedule. From RFK, Jr. (https://www.bmj.com/content/392/bmj.s145?nbd_source=adestra&nbd=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)
    • The United States says it will soon leave the WHO and that it will not pay the outstanding dues (https://www.elespanol.com/ciencia/salud/20260123/eeuu-anuncia-salida-efectiva-organizacion-mundial-salud-oms-insiste-no-pagara-cuotas-pendientes/1003744100610_0.html)
    • Trump’s proposals lead to Medicare austerity, offering an increase of less than 1%, which does not satisfy the hopes of insurers (https://www.politico.com/news/2026/01/28/trump-proposal-signals-medicare-austerity-00751365)
    • After donations, the Trump Administration revokes the order that required more staff in nursing homes. According to the New York Times, executives from those companies met with Trump, made a significant donation, and the project was withdrawn (https://www.nytimes.com/2026/01/27/us/politics/after-donations-trump-administration-revoked-rule-requiring-more-nursing-home-staff.html)
    • The psychedelic revolution that never happened. Although RFK, Jr. said at the time that he was going to promote them for mental disorders, that push never materialized (https://www.politico.com/news/2026/01/28/rfk-psychedelics-medicine-veterans-mdma-ptsd-00750414)
  • China
    • China is changing the rules in biotech. For over 100 years, the USA was the undisputed leader in biomedical research and innovation. China’s major advances put the US at risk of losing that position (https://www.science.org/doi/10.1126/science.aef7757)
  • India
    • India alerts over a deadly Nipah outbreak as other countries tighten controls. Indian health authorities are working against the clock to contain a new cluster of the Nipah virus detected in West Bengal, in the east of the country, after five infections were confirmed and around one hundred people were preventively isolated. (https://www.elmundo.es/ciencia-y-salud/salud/2026/01/26/69778d53e85eceda378b459e-video.html)
  • United Kingdom
    • Home births: Several trusts have to urgently review their services after the death of a mother and baby (https://www.bmj.com/content/392/bmj.s137?nbd_source=adestra&nbd=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)
    • According to the Prime Minister, the drop in vaccinations in the UK is a “national disgrace.” The vaccination strategy in England is slowing down (https://www.bmj.com/content/392/bmj.s139?nbd_source=adestra&nbd=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)
  • France
    • The Senate rejects The law on end-of-life issues is rejected and sent back to Congress (https://www.lemonde.fr/societe/article/2026/01/28/fin-de-vie-le-senat-rejette-la-loi-sur-l-aide-a-mourir-renvoyee-a-l-assemblee_6664474_3225.html)
    • The tense relations between liberal doctors and the Government. Several demonstrations against the regulation of liberal practice (https://www.lemonde.fr/idees/article/2026/01/27/entre-les-medecins-liberaux-et-l-etat-une-relation-sous-tension-au-risque-de-l-immobilisme_6664316_3232.html)
    • Medical deserts: the government willing to facilitate teleconsultations, currently limited to 20% (https://www.lemonde.fr/societe/article/2026/01/26/deserts-medicaux-le-gouvernement-desserre-un-peu-la-vis-sur-la-teleconsultation_6664220_3224.html)
  • Colombia
    • How politics destroyed a healthcare system model. For the past two decades, Colombia’s healthcare system was seen as a model for the rest of Latin America, both by the WHO and the World Bank. None of this changed President Petro’s mind, and he is trying to impose a change. radical(https://www.bmj.com/content/392/bmj.s76?nbd_source=adestra&nbd=8fbb67008 476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb249 4c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)

National Health Policy

  • Central Government Initiatives
    • The Health Data Space is born, a “step forward” in the transformation of the National Health System. The Minister of Health, Mónica García, closed the 1st National Meeting on Data Spaces, where the creation of the National Health Data Space (ENDS) was announced (https://www.consalud.es/politica/ministerio-sanidad/nace-el-espacio-nacional-de-datos-de-salud-un-paso-adelante-en-la-transformacion-del-sns.html)
    • The State Consortium for Advanced Therapies will have its administrative headquarters in Majadahonda and its scientific headquarters in Barcelona (https://www.diariomedico.com/medicina/politica/consorcio-estatal-terapias-avanzadas-tendra-sede-administrativa-majadahonda-cientifica-barcelona.html)
    • The Veo Plan has already received 54,000 applications since its implementation https://www.consalud.es/politica/ministerio-sanidad/el-plan-veo-ha-recibido-mas-de-54000-solicitudes-desde-su-implementacion.html)
  • Initiatives of the autonomous communities
    • The Galician Health Service (SERGAS) will integrate AI for the massive analysis of 1.8 million clinical images. Galicia promotes the early detection of diseases such as cancer and diabetes through the deployment of intelligent algorithms, the complete digitization of operating rooms, and an electronic health record accessible to all professionals (https://gacetamedica.com/politica/galicia-inteligencia-artificial-imagenes-sergas/)
    • The second phase of the Xenoma Galicia project begins, with 5,000 more tests (https://www.redaccionmedica.com/autonomias/galicia/comienza-la-segunda-fase-del-proyecto-xenoma-galicia-con-5-000-pruebas-mas-3482)
    • Madrid denounces the “irregular” assignment of the scientific direction of the CERTERA project to Catalonia (https://www.consalud.es/autonomias/c-madrid/madrid-denuncia-irregularidades-en-la-asignado-a-cataluna-de-la-direccion-cientifica-del-certera.html)
    • Healthcare The Basque Health Service admits it mistakenly administered expired vaccines to 253 people, mostly babies (https://elpais.com/sociedad/2026-01-27/la-sanidad-vasca-administra-por-error-vacunas-caducadas-a-253-personas-la-mayoria-bebes.html)
    • La Rioja strengthens research with €12.8 million (https://www.consalud.es/autonomias/la-rioja/la-rioja-reforzara-la-investigacion-y-la-innovacion-sanitaria-con-una-inversion-de-hasta-1286-millones-de-euros.html)
  • Framework Statute
    • Health Ministry signs agreement with unions on the Framework Statute, but without the support of doctors (https://elpais.com/sociedad/2026-01-26/sanidad-firma-un-acuerdo-para-el-nuevo-estatuto-marco-sin-el-apoyo-de-los-sindicatos-medicos.html)
    • Doctors aim to stop the Framework Statute and will take legal action in the European Parliament (https://www.elespanol.com/invertia/observatorios/sanidad/20260130/medicos-aspiran-frenar-estatuto-marco-cortes-emprenderan-acciones-legales-parlamento-europeo/1003744109202_0.html)
    • Vox takes the demand for a Framework Statute to Congress, the Senate, and the Autonomous Communities (https://www.consalud.es/politica/vox-lleva-la-demanda-de-un-estatuto-medico-hasta-el-congreso-senado-y-ccaa.html)
  • FUNCAS
    • A book by FUNCAS questions the (or not) deeply rooted myths about the Spanish public healthcare system. Whether we have the best healthcare system in the world, whether there is a shortage of doctors in Spain, or whether there really is a shortage of 100,000 nurses, are among the topics analyzed (https://diariofarma.com/2026/01/28/un-libro-de-funcas-cuestiona-bulos-o-no-arraigados-sobre-la-sanidad-publica-espanola)
  • CAR T-cell therapy centers
    • Spain now has 40 CAR T-cell therapy centers, reflecting the expansion of advanced therapies. The Ministry has published a report taking stock of Advanced Therapies treatment in 2025, with five new centers and 2,742 applications processed since 2019 (https://gacetamedica.com/politica/40-centros-car-t-terapias-avanzadas/)

Companies

  • International
    • AstraZeneca reaches a $4.7 billion agreement with China to boost obesity drugs (https://www.ft.com/content/c919380d-3f08-4dde-98e2-64e50b7da293)
    • The historic trade agreement between the US and India will boost pharmaceutical trade. The pact will gradually eliminate Indian tariffs on European medicines and seeks to strengthen supply chains in a context of geopolitical tensions.(https://www.consalud.es/salud35/internacional/la-ue-e-india-sellan-un-historico-acuerdo-de-libre-comercio-que-impulsa-el-intercambio-farmaceutico.html)
    • According to Elon Musk, there will be no nursing homes in the future; he claims his robots will be able to protect and care for the elderly. Musk proposes its humanoid robots as a solution to the shortage of caregivers and the high cost of elderly care (https://www.eleconomista.es/tecnologia/noticias/13752514/01/26/en-el-futuro-no-habra-residencias-musk-asegura-que-sus-robots-con-ia-seran-increibles-para-proteger-y-cuidar-a-las-personas-mayores.html)
    • Bayer begins to see the light at the end of the tunnel, moving away from litigation and focused on its business (https://cincodias.elpais.com/mercados-financieros/2026-02-01/bayer-comienza-a-ver-la-luz-a-final-del-tunel-alejada-de-litigios-y-centrada-en-el-negocio.html)

7 days in healthcare (January 19th-25th, 2026)

 

Summary

The most impactful healthcare news of the week included:

  • Biomedicine: AI trends in healthcare in 2026 analyzed.
  • Global health: Venezuelan doctors speak out and denounce the situation in the healthcare sector.
  • International health policy: The UK’s good idea for customized genetic medicines, proposing a new reimbursement system.
  • National health policy: Doctors increase pressure on the Health Ministry and call for a week-long strike each month until June.
  • Business: “Big Tobacco” companies are evolving into “Big Nicotine”.

Biomedicine

  • AI trends in healthcare in 2026. The trends that seem clear and very positive, according to Bertalan Mesko, are: 1. Language models; 2. Home blood collection; 3. An improvement in longevity, integrating this approach into our daily lives; 4. Healthcare navigation systems; 5. The beginning of heart rate variability analysis; 6. The year of the consolidation of “scribes” in consultations; 7. Generative artificial intelligence for pharmaceutical companies.
  • The treatment of a teenager with an ultra-rare disease as a medical milestone. The possibilities of CRISPR technology in these types of diseases.
  • Scientists create a scalpel that provides instant data during surgeries. Researchers at the Institute of Chemical Technology in Prague (UCT Prague) have developed and validated the “laboratory in a scalpel” concept.

Global Health

  • Venezuelan doctors speak out. Doctors denounce the ongoing repression and the multiple failures of the health system, as medicines are scarce and very expensive, waiting lists grow endlessly, and the exodus of doctors is constant.
  • “Made in Africa” ​​laboratories to detect epidemics in record time. The Pasteur Institute in Dakar is leading a project to monitor the emergence of diseases such as Ebola, dengue fever, and yellow fever in more than a dozen countries. They are seeking a faster response time and to reduce dependence on foreign aid.

International Health Policy

  • The UK’s good idea for customized genetic medicines. The UK is testing a new funding system for these medicines, not based, as is customary, on sales volume. Only with a different reimbursement system will it be possible to develop medicines for ultra-rare diseases.
  • Trump’s second term and the weaponization of healthcare. This article lists all of Trump’s attacks on the healthcare system.
  • Much more land would be needed to comply with the red meat-rich diet proposed by RFK, Jr. The 25% increase in meat and dairy products would require 100 million more acres of land for agriculture.

National Health Policy (Spain)

  • Doctors increase pressure on the Health Ministry and call for a week-long strike each month until June. The first strike will begin on February 16th, and the unions are calling for a “united demonstration” two days prior in Madrid. The Secretary General of CESM, in response to the proposed indefinite strike, reiterates the demand for a medical statute similar to those in Portugal, the United Kingdom, and Germany.

Companies

  • International
    • “Big Tobacco” companies are evolving into “Big Nicotine.” Companies such as British American Tobacco and Philip Morris are reorienting their businesses toward nicotine-based alternatives.
    • Trump’s attacks on the pharmaceutical industry are driving increased interest from funds in this sector in Europe. The value of private equity transactions in Europe has increased by 70%, while in the United States it has grown by only 20%.
  • National
    • The health insurance sector once again stands out above the rest of the insurance industry and is projected to grow by 11.43% in 2025. Health insurance premiums totaled €13.443 billion, and among its varieties—healthcare assistance, reimbursement, and subsidy—the first stands out, having grown by 12.08%.

Biomedicine

  • A new study highlights the brain’s role in the immune system. This is demonstrated in a study with volunteers conducted in Israel and published in Nature Medicine (https://www.economist.com/science-and-technology/2026/01/21/a-new-study-highlights-the-brains-role-in-immune-health)
  • Blood biomarkers for Alzheimer’s. These tests are cost-effective, minimally invasive, and highly accessible (https://doi.org/10.1001/jama.226049)
  • AI trends in healthcare in 2026. The trends that appear clear and very positive, according to Bertalan Mesko, are: 1. Language models; 2. Home blood collection; 3. An improvement in longevity by integrating the approach into our daily lives; 4. Healthcare navigation systems; 5. The beginning of heart rate variability analysis; 6. The year of the consolidation of “scribes” in consultations; 7. Generative artificial intelligence for pharmaceutical companies (https://medicalfuturist.com/top-digital-health-and-healthcare-ai-trends-to-watch-in-2026)
  • Treating a teenager with an ultra-rare disease as a medical milestone. The possibilities of CRISPR technology in these types of diseases (https://www.economcom/science-and-technology/2026/01/19/treatment-of-a-teenager-with-an-ultra-rare-condition-is-a-medical-milestone)
  • Some immune systems defeat cancer: a possible drug? Researchers found an antibody that appears to play a role in people with a better prognosis for lung cancer. But translating that into a drug can be difficult (https://www.nytimecom/2026/01/22/health/lung-cancer-antibodies-immune-system.html)
  • How air pollution impacts ALS risk. A study finds that pollution also accelerates the progression of amyotrophic lateral sclerosis (https://www.abc.es/salud/enfermedades/relacion-contaminacion-aire-mayor-riesgo-ela-20260121145800-nt.html)
  • The baby saved with CRISPR and four other scientific milestones in 2025 (https://elpais.com/expres/2025-12-09/el-bebe-salvado-con-crispr-y-otros-cuatro-hitos-de-la-ciencia-en-2025.html)
  • Genetic variants identified that explain why 15% of pregnancies end in miscarriage. A study of 140,000 embryos shows with unprecedented detail how less than half of human conceptions survive to birth (https://www.abc.es/salud/enfermedades/explican-embarazos-terminan-abortos-espontaneos-20260121170023-nt.html)
  • The bacteria that causes syphilis was already present in the Americas 5,500 years ago (https://elpais.com/ciencia/2026-01-22/la-bacteria-causante-de-la-sifilis-ya-estaba-en-america-hace-5500-anos.html). Access the original article: https://www.science.org/doi/10.1126/science.adw3020
  • A large study rules out that drugs like omeprazole increase the risk of stomach cancer, as suggested by previous studies (https://www.ecom/directivos/estilo-vida/salud/2026/01/22/6970b2fde5fdead8798b4577.html). Access the original article: https://www.bmj.com/content/392/bmj-2025-086384
  • Scientists create a scalpel that provides instant data during surgery. Researchers at the Institute of Chemical Technology in Prague (UCT Prague) have developed and validated the concept of a “scalpel-like laboratory” (https://www.consalud.es/saludigital/innovacion-tecnologica/disenan-un-bisturi-que-permite-obtener-informacion-sobre-la-cirugia-en-tiempo-real.html)

Global Health

  • To properly assess progress in global health, high-quality evidence is needed (https://www.nature.com/articles/d41586-026-00073-2). To this end, the journal Nature has published a new article titled Nature Health, specifically to measure the correlation between policy and practice.
  • Sudan: Infectious diseases are on the rise in rural areas (https://www.bmj.com/content/392/bmj.s87)
  • Venezuelan doctors are speaking out. Doctors report that repression continues and the healthcare system suffers from multiple failures, with medicines scarce and prohibitively expensive, waiting lists constantly growing, and a steady exodus of doctors (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00134-0/fulltext).
  • Bill Gates and OpenAI contribute $50 million to expand AI use in African clinics. They hope to bring AI to more than 1,000 clinics in Rwanda and other African countries, with the aim of expanding access to quality healthcare in poor countries (https://www.ft.com/content/94e685da-f41d-4625-8585-768d7f901c35)
  • Microplastics are no longer a public health emergency in Africa, according to the African Union Health Agency (https://www.lemonde.fr/afrique/article/2026/01/24/la-mpox-n-est-plus-une-urgence-de-sante-publique-en-afrique-annonce-l-agence-de-sante-de-l-union-africaine_6663944_3212.html)
  • Is the threat of microplastics really that serious? The problem is real, but several studies claim that the figures are inflated. A study published in Nature concludes that estimates of their presence in the air could be exaggerated by between 100 and 10,000 times (https://elpais.com/clima-y-medio-ambiente/2026-01-21/es-tan-grave-la-amenaza-de-los-microplasticos-el-problema-es-real-pero-varias-investigaciones-denuncian-que-las-cifras-estan-infladas.html). Access the original article: https://www.nature.com/articles/s41586-025-09998-6
  • “Made in Africa” laboratories to detect epidemics in record time. The Pasteur Institute in Dakar is leading a project to monitor the emergence of diseases such as Ebola, dengue fever, and yellow fever in more than a dozen countries. They are seeking a faster response time and to reduce dependence on foreign countries (https://elpais.com/planeta-futuro/2025-12-02/laboratorios-made-in-africa-para-detectar-epidemias-en-tiempo-record.html)

International Health Policy

  • USA
    • Trump’s second term and the weaponization of healthcare. This article lists all of Trump’s attacks on the healthcare system (https://www.bmj.com/lookup/doi/10.1136/bmj.s91)
    • The US’s return to the WHO may depend on Trump’s ability to impose his new director, as the position is up for renewal next year. According to Politico, the US’s return will depend on whether Trump likes the new director (https://www.politico.com/news/2026/01/22/who-world-health-organization-trump-tedros-00740545)
    • Much more land would be needed to comply with the high-red-meat diet proposed by RFK, Jr. The 25% increase in meat and dairy products would require 100 million more acres of land for agriculture (https://www.theguardian.com/environment/2026/jan/20/rfk-jr-trump-meat-diet-guidelines-land)
    • Republicans will face intense pressure to support Trump’s healthcare plan. A lack of Democratic support would mean the plan would not pass the Senate under current rules (https://www.politico.com/news/2026/01/20/trump-health-plan-congress-00734445)
    • Kennedy’s anti-vaccine policy unites Democrats and Republicans against him. The Health Secretary appeared before the Senate after firing the director of the Centers for Disease Control and Prevention over disagreements about vaccines (https://elpais.com/sociedad/2025-09-04/la-politica-antivacunas-de-kennedy-une-a-democratas-y-republicanos-en-su-contra.html)
    • Big insurers try to blame hospitals and the pharmaceutical industry for the increase in healthcare spending in the USA. In two appearances before Congress, the executives were accused of failing to control healthcare spending (https://www.nytimes.com/2026/01/22/health/health-insurers-obamacare-congress.html)
  • China
    • China’s birth rate plunges to its lowest level since 1949. China’s population has declined for four consecutive years (https://www.nytimes.com/2026/01/18/business/china-population-data.html)
  • India
    • Advances in healthcare, India’s ambitions. It aims to become a developed nation by 2047 (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02636-4/fulltext)
  • United Kingdom
    • The UK’s good idea for customized genetic medicines. The UK is testing a new funding system for these medicines, not based, as is usual, on sales volume (https://www.economist.com/leaders/2026/01/22/britains-good-idea-for-custom-genetic-medicines)
    • NHS regions should be part of the NHS, not the Department (https://www.kingsfund.org.uk/insight-and-analysis/blogs/nhs-regions-department)
    • The Nuffield Trust’s response to the NHS’s online hospitals proposal. The article proposes that the seven regions become health authorities, rather than relying solely on the Ministry (https://www.nuffieldtrust.org.uk/news-item/nuffield-trust-response-to-plans-set-out-for-nhs-online-hospital)
    • Health insurers are growing at a record pace, among the problems facing the NHS, particularly due to insurance companies offering plans to their employees, given the difficulty of accessing the public system (https://www.ft.com/content/ef58761a-bf03-4eef-8a89-f31e193e51f7)

National Health Policy

  • Central Government Initiatives
    • From Funding Medicines to Funding Indications: A Silent Shift in the NHS. Analysis of public funding for medicines reveals a profound shift in the NHS: decisions are not being reduced, but their scope is. Total funding for authorized indications has been steadily declining in recent years. (https://diariofarma.com/2026/01/20/de-financiar-medicamentos-a-financiar-indicaciones-asi-es-el-giro-silencioso-del-sns)
  • Regional Government Initiatives
    • The Ayuso government imposes fines on 7 public/private hospitals for failing to meet quality standards. EL PAÍS has obtained internal documents showing that €2.2 million was not paid to hospitals between 2021 and 2024 due to maintenance or laundry failures (https://elpais.com/espana/madrid/2026-01-22/el-gobierno-de-ayuso-impone-multas-a-siete-hospitales-publico-privados-por-incumplir-los-estandares-de-calidad.html)
    • Valencian Community: the “new” primary care is launched (https://www.diariomedico.com/medicina/medicina-familiar/comunidad-valenciana-nueva-atencion-primaria-ve-luz.html)
    • The Basque Country launches a pioneering model that unites doctors and social services in a single space (https://www.consalud.es/autonomias/pais-vasco/el-pais-vasco-estrena-un-modelo-pionero-que-une-medicos-y-servicios-sociales-en-un-solo-espacio.html)
    • The new Faculty of Medicine arrives in La Rioja (https://www.consalud.es/autonomias/la-rioja/la-nueva-facultad-de-medicina-llega-este-2026-a-la-rioja-nuestro-ecosistema-sanitariose-va-a-fortalecer.html)
    • Osakidetza awards 60 hard-to-fill family doctor positions (https://www.redaccionmedica.com/autonomias/pais-vasco/osakidetza-adjudica-60-plazas-de-dificil-cobertura-a-medicos-de-familia–6471)
  • MIR (Medical Residency Exam)
    • A chaotic MIR exam begins (https://www.elconfidencial.com/salud/2026-01-21/mir-2026-que-es-preguntas_4287426/)
    • Nearly 800 unsuccessful applicants will be able to take the exam (https://www.elmundo.es/ciencia-y-salud/salud/2026/01/24/6973a8bd21efa05a4c8b45d8.html)
  • Framework Statute
    • Doctors increase pressure on the Health Ministry and call for a week-long strike each month until June. The first strike will begin on February 16, and the unions are calling for a “united demonstration” two days prior in Madrid (https://elpais.com/sociedad/2026-01-22/los-medicos-convocan-una-semana-de-huelga-al-mes-desde-el-16-de-febrero-para-exigir-un-estatuto-propio.html)
    • “The European medical profession has its own statutes, so why is Spain the exception?” The Secretary General of CESM, in response to the proposed indefinite strike, reiterates the demand for a medical statute like those in Portugal, the United Kingdom, and Germany. (https://www.diariomedico.com/medicina/profesion/profesion-medica-europea-estatutos-propios-espana-excepcion.html)
  • Artificial intelligence
    • 90% of young people use AI for health consultations before going to the doctor. One in four Spaniards admits to self-diagnosing via the internet, influencers, or AI tools (https://theobjective.com/sanidad/2026-01-25/jovenes-ia-consultas-salud-medico/)
  • Medical Negligence
    • Complaints of medical negligence are skyrocketing in Spain (https://www.elespanol.com/ciencia/salud/20260121/denuncias-negligencia-medica-disparan-espana-crecen-cirugias-esteticas-fallidas-partos-hipoxia/1003744097141_0.html)

Companies

  • International
    • “Big Tobacco” companies are evolving into “Big Nicotine.” Companies like British American Tobacco and Philip Morris are refocusing their businesses on nicotine-based alternatives (https://www.ft.com/content/701f58d2-66f8-4dfb-91de-f49dadecc24e)
    • GSK poised to acquire a food allergy company for $2.2 billion (https://www.ft.com/content/80a5f5fc-59e0-4969-803e-7fd50e4812ba)
    • Trump’s attacks on the pharmaceutical industry are driving increased interest from funds in this sector in Europe. The value of private equity deals in the old continent has risen by 70%, while in the United States it has grown by ‘only’ 20%. (https://www.elespanol.com/invertia/observatorios/sanidad/20260121/ataques-trump-industria-farmaceutica-disparan-interes-fondos-sector-europa/1003744097200_0.html)
    • Abbvie also agrees to price reductions with the Trump Administration (https://www.diariomedico.com/medicina/empresas/abbvie-acuerda-tambien-bajadas-precios-administracion-trump.html)
  • National News
    • The gym business in Spain gains strength in 2025 (https://theobjective.com/economia/2026-01-24/gimnasios-espana-facturacion-2025/)
    • The health insurance sector once again stands out above the rest of the insurance industry and grows by 11.43% in 2025. Health insurance premiums totaled €13.443 billion, and among its varieties—healthcare, reimbursement, and subsidy—the first stands out, having grown by 12.08%. (https://www.diariomedico.com/medicina/empresas/ramo-salud-vuelve-destacar-resto-seguros-crece-1143-2025.html)
    • Miranza reinforces its leadership in ophthalmology with the incorporation of the Bedia clinic in Cantabria (https://www.consalud.es/salud35/nacional/miranza-refuerza-su-liderazgo-en-oftalmologia-con-la-incorporacion-de-clinica-bedia-en-cantabria.html)
    • Sanitas strengthens its healthcare network with a new comprehensive medical center in Alicante by 2027 (https://www.consalud.es/salud35/nacional/sanitas-refuerza-su-red-asistencial-con-un-nuevo-centro-medico-integral-en-alicante-para-2027.html)
    • Galenicum partners with India’s Lupin to manufacture generics of Ozempic (https://www.expansion.com/catalunya/2026/01/23/69727d31e5fdea8f688b458e.html)
    • HM will build a mega-hospital complex in northern Madrid. The Abarca family’s new complex will consist of a hospital, a senior living residence, and a university campus. (https://www.eleconomista.es/salud-bienestar/noticias/13739177/01/26/hm-hospitales-construira-un-megacomplejo-sanitario-en-el-norte-de-madrid.html)
    • Sanofi will transfer the management of its factory in Girona to Adamed Pharma) (https://www.eleconomista.es/salud-bienestar/noticias/13739448/01/26/sanofi-transferira-la-gestion-de-su-fabrica-en-girona-a-adamed-pharma.html)

7 days in healthcare (January 12th-18th, 2026)

 

Summary

The week’s most impactful health news stories were:

  • Biomedicine: The trap of “miracle” weight-loss drugs: the rebound effect is faster than with conventional diets.
  • Global health: The Lancet Commission on improving post-COVID health finds that international agreements are failing to reduce three closely linked health threats.
  • International health policy: Trump unveils the new health plan, albeit with few details (the entire plan is a single sheet of paper).
  • National health policy: Pensions and public healthcare at risk for the first time in Spain, according to Davos.
  • Business: A generic Ozempic for €15 a month, or how to revolutionize the obesity drug market.

Biomedicine

  • The trap of “miracle” weight-loss drugs: the rebound effect is faster than with conventional diets. An analysis of 37 studies reveals the hidden side of GLP-1 agonists: the large-scale study shows that weight returns in less than two years.
  • Predicting type 2 diabetes risk from a drop of blood. A study identifies a blood signature that better predicts the risk of type 2 diabetes.
  • A vaccine to prevent colon cancer shows promising results. The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors compared to the general population.
  • Seven biomarkers can reveal the risk of multimorbidity through a blood test. A study from the Karolinska Institute asserts that “altered metabolism, stress responses, and energy regulation are among the main drivers of multimorbidity in older adults.”

Global Health

  • The Lancet commission on improving post-COVID health. A large number of international agreements are failing to reduce three closely linked threats: non-communicable diseases, infectious disease outbreaks, and environmental degradation.

International Health Policy

  • Trump unveils the new health plan, albeit with few details. The plan’s key elements are lower drug prices and “personal savings accounts” to give money to citizens, rather than to insurance companies. The new plan is only one page long. After so many announcements, more specific proposals could have been considered.
  • National health spending in the USA rose (7.2%) for the second consecutive year in 2024. Hospital costs and medications are the components of spending that have increased the most. The insured population was 91.8% in 2024, up from 92.5% in 2023. Healthcare spending grew faster than the overall economy, rising from 17.7% of GDP in 2024 to 18% in 2025.
  • The new US food pyramid: a step backward that benefits the industry. The pseudoscientist Robert F. Kennedy Jr. has inverted the food pyramid to promote red meat and other animal proteins.
  • The improvement in research in China: a global opportunity. It is the most productive nation in terms of scientific publications.
  • The WHO warns that low taxes on alcohol and sugary drinks increase health risks and calls on governments to raise and update taxation to fund healthcare.
  • HERA (the EU’s Health Emergency Preparedness and Response Authority) prioritizes the assessment of EU health threats in four areas: respiratory viruses, animal transmission, AMR (adverse drug reactions), and armed conflict.

National Health Policy (Spain)

  • Pensions and public healthcare are at risk for the first time in Spain, according to Davos. The World Economic Forum’s Global Risks report identifies “insufficient public services, such as social protection, education, infrastructure, and pensions” as among Spain’s greatest risks. This is a major setback for the Sánchez government, which boasts of protecting and improving public services.
  • The Ministry of Health will not meet with doctors and rules out a future agreement: “What they are asking for is impossible.” This attitude is absolutely intolerable. What doctors are asking for is a specific statute, that is, a way to guarantee a certain degree of “medical leadership” in healthcare, which is necessary. Without undervaluing teamwork and the contribution of other professionals, the doctor/patient relationship remains the core activity of any healthcare system.
  • Record competition for the MIR exam in 2026 will leave 7,487 applicants without a residency position. This is a good way to replicate the problem of “leftovers” (proliferation of doctors without a specialty), which affected the system a few years ago.

Companies

  • International
    • A generic Ozempic for €15 a month: how to revolutionize the obesity drug market. This is because the patents for semaglutide, the key ingredient in Ozempic and the Wegovy weight-loss brand, are beginning to expire worldwide.
  • National
    • Rob Surgical will invest €50 million and open its surgical robot plant in El Prat. Bitrack, the first surgical robot designed and manufactured in Catalonia, is moving towards the market.

Biomedicine

  • The Lancet study finds no increased risk of autism when pregnant women take paracetamol. Trump’s claims that women who take paracetamol during pregnancy are at risk of having children with autism are not supported by any evidence, according to The Lancet (https://www.ft.com/content/18ac00eb-0ab4-478c-9a5b-e4c4c5b47d1c). Access the original article: https://www.thelancet.com/journals/lanogw/article/PIIS3050-5038(25)00211-0/fulltext
  • Research: The Fleming Initiative. An Imperial College project seeking a solution to bacterial resistance to antibiotics (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00087-5/abstract)
  • Most cases of Alzheimer’s are linked to a single gene. Although APOE is linked to Alzheimer’s, very few treatments in clinical trials directly target this gene (https://www.abc.es/salud/enfermedades/mayoria-casos-alzheimer-relacionados-variantes-solo-gen-20260109134521-nt.html).
  • The trap of “miracle” weight-loss drugs: the rebound effect is faster than with conventional diets. An analysis of 37 studies reveals the hidden side of GLP-1 agonists: the large-scale study shows that the weight returns in less than two years (https://elpcom/salud-y-bienestar/2026-01-07/la-trampa-de-los-medicamentos-milagro-para-adelgazar-el-efecto-rebote-es-mas-rapido-que-con-dietas-convencionales.html). Access the original article in the British Medical Journal: https://www.bmj.com/content/392/bmj-2025-085304
  • Predicting the risk of type 2 diabetes from a drop of blood. A study identifies a blood signature to better predict the risk of type 2 diabetes (https://www.abc.es/salud/enfermedades/predecir-riesgo-diabetes-tipo-partir-gota-sangre-20260114142504-nt.html)
  • Radiology and AI, natural allies? Hospitals using algorithms detect clinical cases better and faster, but to expand their use, it is still necessary to unify criteria and have healthcare systems capable of integrating them on a large scale (https://elpais.com/proyecto-tendencias/2025-12-10/radiologia-e-ia-aliadas-naturales-me-ayuda-a-no-pasar-por-alto-hallazgos-sutiles.html)
  • A vaccine to prevent colon cancer shows promising results. The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors compared to the general population (https://elpais.com/ciencia/2026-01-16/una-vacuna-para-prevenir-el-cancer-de-colon-muestra-resultados-prometedores.html)
  • AI algorithm revolutionizes the reading of cancer biopsies in one minute. The SMMILe tool, tested on six types of cancer, allows for precise tumor mapping from basic data, accelerating diagnosis and bringing personalized treatment closer thanks to AI (https://www.consalud.es/saludigital/tecnologia-sanitaria/avances-en-ia-aceleran-el-analisis-del-cancer-un-algoritmo-reduce-a-un-minuto-la-lectura-de-biopsias.html)
  • AI outperforms radiologists in pancreatic cancer detection and promises early diagnoses. The system achieved 38% fewer false positives and 92% accuracy, according to a study with data from nearly 400 patients (https://www.consalud.es/saludigital/innovacion-tecnologica/un-modelo-de-ia-supera-a-radiologos-en-la-deteccion-del-cancer-de-pancreas-y-abre-la-puerta-a-diagnosticos-tempranos.html)
  • Seven biomarkers can reveal the risk of multimorbidity through a blood test. A study from the Karolinska Institute states that “alterations in metabolism, stress responses, and energy regulation are among the main drivers of multimorbidity in older adults” (https://diariofarma.com/2026/01/10/siete-biomarcadores-pueden-revelar-el-riesgo-de-multimorbilidad-a-traves-de-un-analisis-de-sangre). Original article in Nature: https://www.nature.com/articles/s41591-025-04038-2

Global Health

  • The ceasefire does little to improve the “horrific” situation in Gaza. Two new reports detail the harm suffered by women and children (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00086-3/fulltext)
  • The decline in smokeless tobacco (ST) use and oral cancer in a global perspective. ST is used by more than 360 million people and is classified as a Group 1 carcinogen by the International Agency for Research on Cancer (https://www.nejm.org/doi/full/10.1056/NEJMp2500631)
  • The Lancet’s commission on improving post-COVID health. A large number of international agreements are failing to reduce three closely linked threats: non-communicable diseases, outbreaks of infections, and environmental degradation (https://www.thelancet.com/action/showPdf?pii=S0140-6736%2825%2902061-6)

International Health Policy

  • USA
    • Trump unveils new health plan, albeit with few details. The oft-announced plan focuses on “personal savings accounts” and providing money to citizens, rather than to insurers (https://www.nytimes.com/2026/01/15/us/politics/trump-health-care-plan.html). Information on this topic according to Politico: https://www.politico.com/news/2026/01/15/trump-health-outline-00730933. Access to “The Great Healthcare Plan”—though it’s called “great,” the plan is just one sheet of paper: https://www.whitehouse.gov/wp-content/uploads/2026/01/The-Great-Healthcare-Plan.pdf
    • National health spending rose (7.2%) for the second consecutive year in 2024. Hospital and drug costs are the components of spending that have increased the most. The insured population was 91.8% in 2024, up from 92.5% in 2023 (https://www.politico.com/news/2026/01/14/national-health-spending-soars-in-2024-00728963). Access the original source in Health Affairs: https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2025.01683
    • The new US food pyramid: a return to the past that benefits industry. Pseudoscientist Robert F. Kennedy Jr. has turned the food pyramid on its head to promote red meat and other animal proteins (https://elpais.com/salud-y-bienestar/2026-01-10/la-nueva-piramide-nutricional-de-ee-uu-una-vuelta-al-pasado-que-beneficia-a-la-industria.html)
    • The Trump Administration says some approved child vaccines need better studies, while scientists disagree (https://www.science.org/content/article/trump-administration-says-some-approved-childhood-vaccines-need-better-studies)
    • Trump announces withdrawal from 66 global organizations. On January 7, Trump signed an executive order announcing the withdrawal of a number of organizations, which he claims are contrary to U.S. interests (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00085-1/fulltext)
    • Abortion opponents threaten to withdraw their support in the midterm elections due to disagreements with Trump (https://www.politico.com/news/2026/01/15/abortion-opponents-revamp-their-midterms-plans-as-rift-with-trump-widens-00729224)
  • China
    • Upgrading research in China: a global opportunity. It is the most productive nation in terms of scientific publications (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00084-X/fulltext)
  • United Kingdom
    • The agreement with Trump on rising drug prices in the UK is a step backward, according to some experts (https://www.ft.com/content/4a903571-5ac7-44e4-b8b7-4191339748f2)
    • Keir Starmer announces greater restrictions on children’s access to social media, concerned about the excessive use of smartphones by children and teenagers (https://www.ft.com/content/d0d239f5-44cd-4c78-be08-ce55670e7808)
  • France
    • Liberal doctors suspend their strike after some government proposals and a promise to renew dialogue (https://lemonde.fr/societe/article/2026/01/16/les-medecins-liberaux-suspendent-leur-greve-annonce-un-syndicat_6662590_3224.html)
  • Japan
    • Japan and the lessons of a healthcare system in transformation, embracing aging and frailty (https://www.redaccionmedica.com/opinion/felix-rubial-7847/japon-y-las-lecciones-de-un-sistema-sanitario-en-transformacion-6031)
  • WHO
    • The WHO warns that low taxes on alcohol and sugary drinks increase health risks and calls on governments to raise and update taxation to finance the Health (https://elpais.com/salud-y-bienestar/2026-01-13/la-oms-alerta-de-que-los-bajos-impuestos-al-alcohol-y-a-las-bebidas-azucaradas-disparan-los-riesgos-para-la-salud.html)
  • European Union
    • The EU is missing the boat on healthcare AI. While Europe has become entangled in over-regulation that demands absolute guarantees before even beginning to experiment, other countries have opted for more flexible and adaptive approaches. (https://www.elespanol.com/opinion/tribunas/20260113/ue-perdiendo-tren-ia-sanitaria/1003744086257_12.html)
    • HERA (Health Emergency Preparedness and Response Authority) prioritizes the assessment of EU health threats in four areas: respiratory viruses, animal transmission, AMR (adverse drug reactions), and armed conflict. (https://diariofarmcom/2026/01/13/hera-prioriza-la-evaluacion-de-amenazas-sanitarias-de-la-ue-en-cuatro-areas)

National Health Policy

  • Impact of General Policy on Health
    • Pensions and public healthcare at risk for the first time in Spain, according to Davos. The World Economic Forum’s Global Risks report identifies “insufficient public services, such as social protection, education, infrastructure, and pensions” as among Spain’s greatest risks. This is a major setback for the Sánchez government, which boasts of protecting and improving public services (https://www.expansion.com/economia/politica/2026/01/14/69674b09468aeb53588b4593.html). Access the Global Risks Report 2026 (21st Edition): https://reports.weforum.org/docs/WEF_Global_Risks_Report_2026.pdf (page 89 lists the risks in Spain: 1. Social polarization; 2. Talent and worker shortages; 3. Inadequate public services and social protection (including education, infrastructure, pensions); 4. Debt (public, corporate, and household); and 5. Lack of economic opportunities and employment)
  • Central Government Initiatives
    • The Ministry of Health will take Ayuso to court for the lack of a registry of abortion conscientious objectors (https://elpais.com/sociedad/2026-01-16/sanidad-denuncia-al-gobierno-de-ayuso-por-no-tener-registro-de-objetores-del-aborto.html)
  • Autonomous Community Initiatives
    • Agreement on healthcare Asturian: 12-hour shifts, reduced appointment schedules in Primary Care, and fewer restrictions on combining public and private healthcare (https://www.diariomedico.com/medicina/profesion/acuerdo-sanidad-asturiana-guardias-flexibles-reduccion-agendas-ap.html)
    • The Valencian Community is preparing new support measures for rural pharmacies, with an emphasis on updating schedules, emergency care, and vacations, “improving work-life balance without compromising the continuity of pharmaceutical services to the public” (https://diariofarma.com/2026/01/15/comunidad-valenciana-prepara-nuevas-medidas-de-apoyo-y-flexibilidad-para-la-farmacia-rural)
    • Farmaindustria and the Catalan Government will promote Catalonia as a major biopharmaceutical hub (https://diariofarma.com/2026/01/15/farmaindustria-y-cataluna-potenciaran-la-region-como-un-gran-polo-biofarmaceutico)
    • The cities vying to host the AESAP: Zaragoza, Granada, Barcelona, ​​Oviedo, León, Murcia, Toledo, Lugo, and Salamanca (https://www.consalud.es/autonomias/las-nueve-ciudades-que-aspiran-a-sede-de-la-aesap-al-descubierto-cuales-son-sus-propuestas.html)
  • Transplants
    • Spain is nearing its all-time record for transplants and has been the world leader for 34 years. (https://elpais.com/sociedad/2026-01-16/espana-roza-su-record-historico-de-trasplantes-de-organos-y-encadena-34-anos-como-lider-mundial.html)
  • Framework Statute
    • The Ministry of Health will not meet with doctors and rules out a future agreement: “What they are asking for is impossible” (https://www.elespanol.com/invertia/observatorios/sanidad/20260116/ministerio-sanidad-no-reunira-medicos-descarta-futuro-acuerdo-piden-imposible/1003744091205_0.html)
  • MIR Exam
    • Medical outrage over the lack of transparency and the Ministry of Health’s poor management in organizing the MIR exam (https://www.larazon.es/sociedad/indignacion-medica-pesima-gestion-falta-transparencia-sanidad-examen-mir_202601126964594ebe7ae37724bfbfcd.html)
    • Record competition for the MIR exam in 2026 will leave 7,487 applicants without a residency position (https://www.elespanol.com/invertia/observatorios/sanidad/20260117/competencia-record-mir-dejara-sin-plaza-aspirantes-examen/1003744092787_0.html)

Companies

  • International
    • Nvidia and Microsoft support an AI breakthrough related to gene therapy. UK’s Basecamp Research uses genomic sequencing databases to address cancers and resistant bacteria (https://www.ft.com/content/29ec4303-cb70-48b5-a28c-320a7062cdd3)
    • From Lilly’s Orforglipron to Novo Nordisk’s CagriSema, the obesity drugs that will break the bank in 2026 (https://www.elespanol.com/invertia/observatorios/sanidad/20260115/orforglipron-lilly-cagrisema-novo-nordisk-farmacos-obesidad-romperan-banca/1003744089743_0.html)
    • 25% of the population would be candidates for GLP-1 treatment. Women and older people more frequently meet the eligibility criteria to receive these obesity drugs. (https://www.diariomedico.com/medicina/medicina-preventiva/25-poblacion-mundial-seria-candidata-tratamiento-glp-1.html)
    • The ten largest acquisitions in the pharmaceutical industry in 2025 (https://elglobalfarma.com/industria/diez-mayores-adquisiciones-industria-farmaceutica-2025/)
    • Johnson & Johnson, Novartis, and MSD lead the biggest acquisitions of 2025 (https://www.eleconomista.es/salud-bienestar/noticias/13722104/01/26/johnson-johnson-novartis-y-msd-lideran-las-mayores-compras-en-2025.html)
    • A generic Ozempic for 15 euros a month, or how to revolutionize the market Obesity drugs. This is because the patents for semaglutide, the key ingredient in Ozempic and the Wegovy weight-loss brand, are beginning to expire worldwide (https://cincodias.elpais.com/companias/2026-01-15/un-ozempic-generico-a-15-euros-al-mes-o-como-revolucionar-el-mercado-de-farmacos-para-la-obesidad.html)
  • National News
    • The government will require health insurers to have a viability plan (https://www.redaccionmedica.com/secciones/privada/el-gobierno-obligara-a-las-aseguradoras-de-salud-a-tener-plan-de-viabilidad-4645)
    • Esteve strengthens its position in the USA with the purchase of TerSera’s infusion therapies (https://www.diariomedico.com/farmacia/industria/esteve-fortalece-eeuu-compra-terapias-infusion-tersera.html)
    • Italfármaco announces a €10 million investment in its Madrid center (https://diariofarma.com/2026/01/12/italfarmaco-anuncia-una-inversion-de-10-millones-de-euros-en-su-centro-madrileno)
    • Rob Surgical will invest €50 million and open its surgical robot plant in El Prat. Bitrack, the first surgical robot designed and manufactured in Catalonia, is moving towards the market (https://www.expansion.com/catalunya/2026/01/16/696aabf0e5fdea60278b458f.html)